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AIM OF THE STUDY 
 
To compare the efficacy of Inj. Phenylephrine hydrochloride  
















 Spinal anaesthesia is a commonly used regional technique for 
lower abdominal, perineal, obstetrics, gynaecological and lower limb 
surgeries.  It offers excellent anaesthesia and fewer side effects than 
general  anaesthesia. It is easy to perform and provides faster onset and 
effective sensory and motor blockade.    Hypotension is one of the most  
common and frequently observed complication encountered in spinal 
anaesthesia . Recently inj. phenylephrine  hydrochloride an alpha1 
receptor agonist has been used in the treatment of spinal hypotension in 
obstetric surgery  because it is  shown to improve the uterine perfusion 
and fetal circulation. Since the study has been done  in  obstetric  cases 
we have decided  to evaluate the efficacy of inj. phenylephrine  
hydrochloride in general surgical cases. This study is  designed  to 
evaluate the efficacy of inj. phenylephrine hydrochloride in  comparison 
to inj. Ephedrine hydrochloride in the treatment of spinal hypotension.  
 SPINAL ANAESTHESIA 
 Spinal Anaesthesia is a form of central neuraxial block in which a  
temporary interruption of nerve transmission is achieved following 
injection of local anesthetic agent in CSF into the subarchnoid  space 
usually below L2 vertebra. 
 Subarachnoid block is one of the most commonly performed 
techniques of regional anaesthesia. It provides excellent operating 
conditions for surgery below the umbilicus. 
ANATOMY  
 The vertebral canal extends from foramen magnum to the sacral 
hiatus. Its boundaries are the dorsal spine, pedicles and lamina of  
successive vertebrae (7 cervical,  12 thoracic, 5 Lumbar and 5 sacral).The 
vertebrae are held together by overlapping ligaments namely anterior and 
posterior  longitudinal ligaments,  Ligamentum Flavum,  interspinous 
ligament, supraspinous ligament and the inter vertebral discs. 
 The spinal cord is a direct continuation of medulla oblongata which 
begins at the upper border of atlas and terminates distally in the conus 
medullaris. 
 The distal termination, because of the differential growth rates 
between the vertebral canal and spinal cord varies from L3 in the infant to 










  Surrounding the spinal cord in the bony vertebral column are three 
membranes (from within to periphery) The piamater, arachnoid mater, 
and the duramater. 
 The piamater is a highly vascular membrane that closely invests the 
spinal cord. 
 The arachnoid mater is a delicate non vascular membrane closely 
attached to outer most duramater. 
STRUCTURES TO BE PIERCED FOR SUBARACHNOID BLOCK  
 Subarachnoid space is present between the piamater and the 
arachnoid mater. In this space, the cerebrospinal fluid (CSF), spinal 
nerves, blood vessels that supply the spinal cord and dentate ligaments 
are present. Although the spinal cord ends at lower border of L1 in adults, 
the subarachoid space continues upto S2.  
 The outer most membrane in the spinal cord is the longitudinally 
organized fibroblastic membrane, the duramater. This layer is the direct 
extension of cranial duramater and extends as spinal duramater from 
foramen magnum to S2, where filum terminale blends with periosteum of 
subdural space which contains small amount of serous fluid to allow dura 
and arachnoid to move over each other. 
 Surrounding the duramater is the epidural space which extends 
from foramen magnum to sacral hiatus. Posterior to the epidural space is 
ligamentum flavum. 
  Immediately posterior to the ligamentum flavum is interspinous 
ligament. Extending from the external occipital protuberance to the 
coccyx, posterior to this structure is the supra spinous ligament, lumbar 
puncture is routinely performed at  interspace from L2 to L5  to avoid 
damage to the spinal cord which ends at lower border of L1 vertebra in 
adults. 
PHYSIOLOGY OF SUBARACHNOID BLOCK 
CEREBROSPINAL FLUID 
 The cerebrospinal fluid is an ultra filtrate of the blood plasma 
which is in hydrostatic and osmotic equilibrium. It is a clear, colourless 
fluid found in the spinal and cranial subarachnoid space and in ventricles 
of  the brain. 
 The average volume of CSF in adults ranges from 120 to 150ml of 
which 35ml is in the ventricles, 25ml in the cerebral subarachoid space 
and 75ml  in the spinal subarachoid space. It is secreted by choroid plexes 
at a rate of  0.3-0.4ml/minute. 
 PHYSICAL CHARACTERISTICS OF CEREBROSPINAL FLUID 
PH    7.4 
Specific gravity 1.007 
Density  1.003 
Baricity  1.000 
Pressure  8-12 mm Hg/70-80 CM H2O 
Cells    3-5 /cu.mm 
Proteins  20 mg/dl 
Glucose  45-80 mg/dl   
 The cerebrospinal fluid plays an important role in spinal 
anaesthesia as a media for dispersion of the local anaesthetic drug to the 
spinal nerve. 
An important factor determining the spread of drugs in 
subarachnoid space is specific gravity of the injected solution compared 





DIAGRAM OF DERMATOMES 
 
 MECHANISM OF SPINAL ANAESTHESIA 
 Injection of local anaesthetics into the spinal CSF allows access to 
sites of action both within the spinal cord and the peripheral nerve roots, 
the nerve roots leaving the spinal canal are not covered by epineurium 
and are readily exposed to the local anaesthetic with in CSF.  
Therefore afferent impulses leaving via ventral nerve roots are 
blocked during spinal anaesthesia. Spinal local anaesthetics block sodium 
channels and electrical conduction in spinal nerve roots.  
Local anaesthetics can exert sodium channel block within the 
dorsal and ventral horns inhibiting the generation and propagation of 
electrical activity.  
The order in which nerve fibers are blocked in spinal anaesthesia is 
preganglionic sympathetic B fibres, followed by temperature fibres (cold 
before warmth), fibers carrying pin prick sensation, touch, deep pressure 
and finally proprioception. Motor blockade is the last to occur. Recovery 
is in the reverse order. 
 The major factors determining the level of blockade after 
subarachnoid block are the baricity of the local anaesthetic solution, the 
position of the patient before and after injection and dose of the 
anaesthetic  agent injected. 
 FATE OF LOCAL ANAESTHETICS IN SUBARACHNOID SPACE 
Following injection of local anaesthetic solution into subarachnoid 
space, its concentration falls rapidly. The initial steep fall is due to mixing 
of drug with CSF and subsequent absorption into nerve roots and spinal 
cord and into blood vessels. 
 Depending on the type of drug used, it is metabolized in liver or in 
plasma by pseudocholinesterase. The addition of a vasopressor to the 
local anaesthetic will retard the absorption of the drug and thus increases 
the duration of anaesthesia and analgesia. 
ADVANTAGES OF SPINAL ANAESTHESIA 
• Cost effective 
• Excellent analgesia 
• Patent airway 
• Adequate muscle relaxation 
• Minimal  blood  loss 
• Less respiratory complications 
• Lower incidence of DVT and   Pulmonary emboli. 
INDICATIONS OF SUBARCHNOID BLOCK 
Spinal anaesthesia can be administered whenever a surgical 
procedure  warrants  a  sensory level of anaesthesia that does not produce 
adverse patient outcome. 
 It is a desired technique for 
 Lower abdominal surgeries 
 Lower limb surgeries 
 Urological procedures 
 Obstetrics and gynecological procedures 
 Perineal and rectal surgeries 
CONTRAINDICATIONS FOR SUBARACHNOID BLOCK 
 Absolute contraindication : 
 Patient’s  refusal   
 Uncorrected  coagulopathy 
 Uncontrolled blood loss/ shock 
 Fixed cardiac output states 
 Raised intracranial pressures 
Relative contraindications : 
 Local sepsis 
 Neurological disease 
 Major spine deformities /Previous surgery on spine 
 Severe cardiac disease  




3. Toxicity due to intra vascular injection 
4. Allergy to local anaesthetic drug 
5. Hypoventilation and   Brain stem hypoxia 
Late 
1. Post dural  punctural headache 
2. Retention of urine 
3. Backache 
4. Meningitis 
5. Transient lesions of cauda  equina 
6. Sixth nerve palsy 
7. Anterior spinal artery syndrome 
 SPINAL ANAESTHESIA TECHNIQUE 
 The first step in successful performance of spinal anaesthesia is 
proper patient selection. 
This is accomplished by pre-anaesthetic evaluation of the patient  
by thorough history, physical examination, laboratory data and 
communication with patient and surgical staff about details of the 
procedure. Reliable intravenous access through large bore intravenous 
cannula (18G/16G) is mandatory. Preloading limits the severity of 
hypotension that may result from sympathetic block. The recommended 




 Preparation of equipment and drugs is essential for performing a 
subarachnoid block. 
The choice of drug is based on the type of surgical procedure and 
the duration of block desired. Spinal needles of various sizes with various 
types of points are available. Two types of spinal needles available: 
1.Quincke-Babcock needle that cut the dural fibres and 
2.Greene,Whitacre and Sprotte needle that are designed to separate the 
dural fibres.  To lower the incidence of post dural puncture headache to a  






 minimum, small bore needles with a rounded non-cutting bevel are 
preferred. 
POSITION 
 The patient can be positioned in any one of the following position, 
depending upon the surgery proposed.   
Lateral  decubitus  position :  
The patient is placed with back parallel to the edge of the operating 
table close to the anaesthesiologist with  neck flexed and thigh flexed 
upon the abdomen.  
Sitting  position :  
It is choosen when low lumbar and sacral  levels of anaesthesia are 
adequate for the surgical procedure or when obesity or scoliosis makes 
identification of mid line anatomy difficult in lateral decubitus position or 
when orthopedic problems of hip and knee exists. Patient made to sit at 
the edge of the table with legs hanging down with both arms hugging the 
pillows. 
Prone   position : 
For  caudal  technique a pillow is used under the anterior iliac 
crests to rotate the pelvis the legs are spread 20 degrees to ease 
identification of  the  sacral  hiatus and the heels are rotated laterally to 
relax the gluteal musculature. 
 PROJECTION AND PUNTURE 
 The spinal puncture can be performed either by a midline or a 
paramedian approach, usually at the L2-L3, L3-L4, L4 –L5 interspaces.  
 The procedure is carried out under strict aseptic conditions. The 
patients back is prepared with an antiseptic solution and sterile drapes are 
applied. A line from the highest point of iliac crest passes through either 
spinous process of L4 or the L4-L5 interspace. The midline approach 
with the patient in sitting position/ right lateral decubitus position is used 
in our study. 
Depending on the interspace and approach selected subcutaneous 
skin wheal is raised over the intended puncture site with local anaesthetic 
solution.  The needle is inserted in the middle of the interface with bevel 
parallel to the longitudinal dural   fibres.  After traversing the skin and 
subcutaneous tissue, the needle is advanced in a slightly cephalad 
direction with the long axis of the vertebral column.  The stylet is 
removed and appearance of cerebrospinal fluid at the hub of the needle 
confirms  position of the needle tip in the subarachnoid space.  Stylet is 
reinserted to prevent excess leakage of CSF. The hub of the needle is 
firmly held between the thumb and index finger of the anaesthesiologist’s 
non dominant hand and back of hand held against patients back to steady 
the needle, while syringe containing anaesthetic solution is firmly 
attached to the needle. 
  After confirming, free flow of spinal fluid by aspiration, the 
anaesthetic solution is injected. The patient is placed in supine position 
immediately. Cardio vascular and respiratory functions are monitered. 
Analgesia is checked by loss of sensation to pin prick. Motor block is 





 MECHANISM OF SPINAL HYPOTENSION 
 One of the most commonest adverse effects of central neurxial 
blockade is spinal hypotension. 
Spinal hypotension is considered when systolic blood pressure falls 
below 90mm Hg or below 30% from the baseline preoperative systolic 
blood pressure.  
Spinal hypotension is caused due to bilateral sympathetic blockade 
from T5-L1 where these fibres mainly maintain the vasomotor tone of the 
arterial and venous smooth muscle. Blocking these nerve fibres causes 
vasodilatation below the level of blockade leading to venous pooling of 
blood. Since 70% of blood volume is contained within the venous 
capacitance vessels there is decreased venous return to the heart leading 
to decrease in cardiac output  producing hypotension. 
  The effects of vasodilatation can be minimized by compensatory 
vasoconstriction of veins above the sympathetic blockade. But in cases of 
high blockade where cardioaccelarator fibres are also blocked (T1-T4) 
severe  hypotension   occurs. 
 THEORIES OF CAUSATION OF FALL IN BLOOD PRESSURE 
1. Diminished cardiac output consequent on reduction of venous 
return to heart, and lack of muscular propulsive force on veins. 
BAINBRIDGE REFLEX: Decreases in venous return results in 
decreased efferent outflow to the cardio accelerator fibers causing 
reduction in heart rate and hypotension. 
2. Paralysis of sympathetic nerve supply to the heart (T1-T4). 
Bradycardia may give rise to fall in cardiac output. 
3. Paralysis of sympathetic nerve supply to adrenal glands 
(splanchnic nerves) with consequent catecholamine depletion. 
4. Absorption of drug into circulation. 
5. Ischaemia and hypoxia of vital centres. 
6. Pre existing   hypovolaemia if present may give rise to severe fall 
in blood pressure if central neural blockade is employed. 
7. Compression of the great vessel within the abdomen by the gravid 
uterus, abdominal tumors or abdominal packs may cause severe 
hypotension in the presence of central neuraxial blockade. 
The degree of hypotension  dependents upon  
(i) Height of the block 
(ii) Extent of venous pooling 
(iii) Degree of upper extremity vasoconstriction. 
 Predictors of hypotension : 
(i) Height of sensory block( T5 or higher ) 
(ii) Elderly age group  
(iii) Systolic blood pressure < 90mm Hg or 30% decrease from  
baseline value  
(iv) Severe hypertension. 
(v) Severe intra vascular volume depletion. 
TREATMENT OF HYPOTENSION  
 Treatment of hypotension should be directed towards the 
underlying mechanisms of decreased cardiac output and systemic 
vascular resistance. 
Positioning of patient : 
 Proper positioning will prevent high ascent of the drug avoiding  
higher level of blockade to produce profound sympathetic blockade. 
Fluid  management : 
(i) Preloading with 10 ml / kg of crystalloids 
(2)      Intra operative  administration of either colloids or crystalloids. 
 Sympathomimetics : 
(i) Ephedrine a both alpha and beta agonist  effect  increases heart rate 
and contractility and also produces vasoconstriction. 
(ii) Phenylephrine an alpha1 agonist produces arteriolar 
vasoconstriction, increase the venous tone, increase venous return 
and  increases systemic vascular resistance. 
(iii) Epinephrine by direct action increases the vascular tone 
Trendelenberg  Position : 
Placing the patient in head down position to produce auto 
transfusion  increases  the venous return.  
Compression bandages :  
With elevation of the leg is done to increase venous return. 
  
      
 EPHEDRINE HYDROCHLORIDE 
Ephedrine is an indirect acting synthetic non-catecholamine similar 




Osmolar  concenration of 5% solution: 0.35 mosm / ml.  
Storage temperature: 15-30˚C 
MECHANISM OF ACTION 
      It stimulates alpha and beta adrenergic receptors.  The 
pharmacological effects of this drug are due to  endogenous release of nor 
epinephrine (indirect acting) but the drug also has direct stimulant effect 
on adrenergic receptors (direct acting) 
METABOLISM 
Ephedrine  is  deaminated in the liver and conjugation occurs.  The 
slow inactivation and excretion of ephedrine are responsible for the 
prolonged duration of action of this sympathomimetic. 
 DURATION OF ACTION 
Orally it acts within 60 mins, maintains its action for 3-5hrs. 
On IV injection, onset of action 3-5 mins, maintains duration of 
action for 10-15mins. 
PRESENTATION 
◊  15/30/60mg tablets 
◊  Elixir syrup 3mg / ml 
◊ 0.5/1% nasal drops 
◊  30mg  | ml injection available as ampoule 
SYSTEMIC EFFECTS 
Cardio vascular system : 
        Intra venous administration of ephedrine results in stimulation of 
alpha receptors there by causing peripheral arterial and venous 
vasoconstriction. 
Stimulation of beta 1 receptor  increases the myocardial 
contractility.  As a result there is increase in systolic and diastolic blood 
pressure, increase in heart rate and increase in cardiac output.  Renal and 
splanchnic blood flows are decreased whereas coronary and skeletal 
muscle blood flow is increased.  Cardio vascular effects of ephedrine 
hydrochloride resemble those of epinephrine but its systemic blood 
pressure elevating response is less intense and last approximately ten 
 times longer. A second dose of ephedrine hydrochloride  produce a less 
intense systemic blood pressure response than the first dose, this 
phenomenon is known as tachyphylaxis, which occurs with many 
sympathomimetics and is related to the duration of action of these drugs. 
      Tachyphylaxis probably represents a persistent blockade of 
adrenergic receptor. Ephedrine hydrochloride induced activation of 
adrenergic receptor persist even after systemic blood pressure returns to 
near predrug levels by virtue of compensatory cardio vascular changes.  
When the second dose of ephedrine hydrochloride is administered at this 
time, the receptor sites still occupied by ephedrine hydrochloride   limits 
the available receptors and the blood pressure response is less.  
Alternatively tachphylaxis may be due to depletion of norepirephrine 
stores. 
Central nervous system : 
Stimulation  of the cerebral cortex and medulla produces alertness, 
anxiety, tremor, twitching and insomnia.  
It stimulates  the  spinal cord and enhances spinal reflex. It crosses 
blood brain barrier and increases MAC. 
Respiratory system : 
      It produces bronchodilation and increases the respiratory minute 
volume 
 
 Gastrointestinal system and urinary system : 
Increases  sphincter tone of bladder and alimentary tract.  It relaxes 
smooth muscle of gastrointestinal tract and the bladder. 
Uterus: 
It does not alter the uterine blood flow . 
DOSE: 
Oral 30-50mg by mouth 
In adults IV bolus 2.5-10mg 
In children IV bolus 0.1mg | kg 
CLINICAL USES 
1. To increase the systemic blood pressure in the presence of 
sympathetic nervous system blockade produced by regional 
anaesthesia or hypotension due to inhaled or injected anaesthetics. 
2. Activation of beta 2 adrenergic receptor causes bronchodilatation, 
hence used in the treatment of bronchial asthma. 
3. Decongestant effect produces symptomatic relief from acute 
coryza. 
 
 PHENYLEPHRINE  HYDROCHLORIDE 
Phenylephrine is a direct acting  synthetic non-catecholamine 





Storage temperature: 15-300C 
MECHANISM OF ACTION 
 It acts mainly on the α1 adrenergic receptors by direct effect.Action 
on  α2 adrenergic receptor  is less. Dose to stimulate α1 receptor is less 
than required to stimulate α2. Only in very large doses it will have 
minimal – β adrenergic activity. 
 It is a powerful post synaptic α receptor stimulant. 
 PHARMACOLOGICAL ACTIONS  
• IV administration causes rise in systolic  and  diastolic blood 
pressure. 
• It is a powerful venoconstrictor than arteriolar constriction causing 
rise in systemic vascular resistance. 
• It produces reflex bradycardia but increase stroke output. 
• Most vascular beds are constricted; renal, splanic, cutanous and 
limb blood flows are reduced but coronary blood flow is increased. 
• Pulmonary vessels are constricted and pulmonary arterial pressure 
is raised. 
METOBOLISM 
 It is metabolized in the liver by monoamine oxides. 
DURATION OF ACTION 
The action of IV Phenylephrine starts within 1 to 2 min after 
administration  and  effective for about 20 minutes. Pheny lephrine when 
given SC / its onset takes about 10 – 15 mins and  effective for about 1 - 2 
hours. 
DOSAGE 
sc / im 2 to 5 mg further doses of 1 to 10 mg  
IV 50 – 200microgms slow IV as 0.1% solution repeated at  20 
minutes interval .  
 An IV infusion containing 10 mg of  phenylephrine in 500ml of 
5% glucose  or 0.9%NS started at a  rate of 180 micro gm / min and later 
reduced to 30-60- micro gm/ min according to the response. 
CLINICAL USES 
1. Used to treat spinal hypotension . 
2.  Hypotension due to peripheral vasodilatation produced by 
administration of injected or inhaled anesthetics. 
3. Useful in patients with coronary artery disease, in aortic stenosis  
and mitral stenosis patients. It increases coronary perfusion 
pressure without chronotropic side effects. 
4. Used as a continuous infusion (20 to 50 microgm/ min) in adults to 
sustain systemic blood pressure at normal levels during carotid 
endartectomy. It slows the heart rate in case of supra ventricular 
tachydysrhythmias.  
5. On topical application, phenylephrine is used as nasal decongestant 
and produces mydriasis without cycloplegia. 
6. Effective in prolonging spinal anaesthesia when added to local 
anaesthetic solution that are placed in the subarachroid place. 
7. Administration of phenylephrine by infusion during caesarean 
section to maintain maternal systolic blood pressure is associated 
with a lower incidence of fetal acidosis than ephedrine. 
 8. Repeated injection produces comparable effects which is an added 
advantage of this drug.  
SIDE EFFECTS 
Cardio vascular effects : 
1. In case of IV injection of phenylephrine given to patients with 
coronary artery disease causes transient impairement of left 
ventricular global function. 
2. Renal, Splanic, Cutanous blood flow decreased. 
3. Pulmonary artery pressure increased. 
4. Reflex bradycardia 
5. Headache  
Metabolic Effects : 
 Stimulation of alpha receptors by a continuous infusion of 
phenylephrine during acute potassium loading interferes with the more 
movement of potassium ions across cell membrane into cells. 
CONTRAINDICATIONS      
1. MAO inhibitors within 14 days   
2. Severe HT       
3. Ventricular tachycardia    
4. Hyperthyroidism     
5. Aortic  valvular  incompetence   
 PRECAUTIONS   
1. IHD 
2.  Cardiac arrythmias 
3.  Occlusive vascular disease 
4.  Angina pectoris 
5.  Hyperthyroidism 
6.  Severe arteriosclerosis 
DRUG INTERACTIONS 
1. Induces Ventricular fibrillation in patients receiving cyclo propane, 
halothane. 
2. Cardiac arrythmias in patients receiving glycoside and quinidine 
PREPARATIONS 
Inj.Phenylephrine  10mg/ml 
Nasal solution 0.125%, 0.25%, 0.5%, 1% 
Opthalmic solution 0.12%, 2.5%, 10% 
Chewable tablets 10 mg 
 REVIEW OF LITERATURE 
Anna Lee et al1 compared the effects of phenylephrine and 
ephedrine to manage hypotension during spinal anaesthesia for elective 
caeserean delivery. Woman given ephedrine had neonates with lower 
umbilical cord blood pH values compared with those given 
phenylephrine. Both groups had similar efficacy for preventing or treating 
hypotension and there was no difference in  clinical neonatal outcome as 
measured by Apgar scores. But the risk of maternal  bradycardia. 
(responsive to atrophine) was larger than in those women given 
ephedrine.  
Brooker et al2 compared the effects of phenylephrine and 
epinephrine in the treatment of  hypotension after hyperbaric Tetracaine 
spinal anaesthesia. A prospective double blind  randomized cross – over 
study design, 13 patients received infusion of epinephrine and 
phenylephrine to manage hypotension after hyperbaric tetracaine. Blood 
pressure, heart rate  and stroke volume (measured by Doppler 
echocardiography using the transmitral time –  velocity integral) were 
recorded at base line, 5 mins after injection of tetracaine and before  and 
after management of hypotension. 
 Phenylephrine was effective at restoring systolic blood pressure 
after SAB (120 + 6 mm Hg to 144 +  5mm Hg p < 0.001) but associated 
with decreased heart rate (80 + 5 beats / min to 60 + 4  beats / min  
p < 0.001) and cardiac output (8.6 + 0.7 L / min to 6.2 + 0.7 L / min  
 p <0.003)   Epinephrine was effective at restoring. systolic blood pressure 
(119 + 5mm Hg to 139 + 6mm Hg p< 0.001) cardiac output (7.8 + 0.6 L / 
min to 10.8 + 1.1L / min p < 0.001). 
 They concluded that ephinephrine increased heart rate, cardiac 
output and restored systolic blood pressure  and phenylephrine decreased 
heart rate decreased cardiac output and restored systolic and diastolic 
blood pressure. 
 Adrienne Stewart et al3 studied the dose – dependent effects of 
phenylepherine for elective caesarian delivery under SAB. 
 A Randomized double blind study was done in 75 women 
scheduled for elective caesarean delivery were allocated to receive a 
phenylephrine infusion at 25microgm / min, 50microgm / min, 
100microgm / min. This infusion was titrated to maintain maternal 
baseline systolic blood pressure from induction of spinal anaesthesia until 
delivery. Heart rate, systolic blood pressure, cardiac output, stroke 
volume  (Suprasternal Doppler moniter) and venous return measured 
(Corrected flow time) and contractility were recorded from baseline and 
then every 5 mins for 20mins after initiation of spinal anaesthesia. Apgar 
scores and umbilical and blood gases were recorded. 
 They concluded that systolic blood pressure was controlled 
satisfactorily in all groups. But when  infusing higher concentration 
(100microgm/min) mother and fetus were subjected to higher  dose of 
 phenylephrine with significant effects on maternal heart rate and cardiac 
output (up to 20%  reductions) . Apgar scores and umblical cord blood 
gases were similar among groups. 
 Paul cly burn et al4 showed that maternal hypotension when treated 
with large doses  of ephedrine contributed to decreased umbilical cord 
pH, but phenylephrine produced less depression of cord pH than 
ephedrine. The explanation for this is ephedrine displays tachyphylaxis 
and frequently large doses are required to treat hypotension. It has a slow 
onset of action and is not ideal in treating sudden hypotension. Ephedrine 
crosses the placenta, it is  possible that acidosis is the result of a direct 
fetal effect. 
 In order to minimize the risk of fetal acidosis, prophylactic 
phenylephrine infusion was started immediately after spinal injection and 
maintained systolic blood pressure. If heart rate falls below 80 beats/ min 
glycopyrronium was administered 
  Warwick D Nagan kee5 studied the methods of managing spinal 
hypotension for caesarian section. He concluded that phenylephrine was 
more effective and can be titrated more easily than ephedrine and it has a 
less depressive effect of fetal pH and base excess. It may be given as 
boluses (50-100microgm) or by infusion (50-100microgm / min). Current 
evidence suggests that infusion are best titrated to maintain maternal 
blood pressure near to base line values. 
  Kocarev et al5 studied the equivalent dose of ephedrine and 
phenylephrine in the prevention of post spinal hypotension in caesarean 
section. They determined the minimum vasopressor dose for each of 
these drugs to calculate the dose ratio for clinical equivalence in the 
prevention of hypotension.  
 Patients undergoing elective caesarean section under spinal 
anaesthesia were  randomized into two groups. Group A received 50mg 
of ephedrine in 0.9% normal saline 500ml at 999ml/hr Group B received 
500microgm of phenylephrine in 0.9%normal saline 500ml at 999 ml / hr.  
They derived at a conclusion that the minimum vasopressor dose in 
saline was 532.9microgm  for phenylephrine and 43.3mg for ephedrine, 
potency ratio of 81.2 for equivalence between  phenylephrine and 
ephedrine in prevention of spinal hypotension. 
 Cooper David et al7 studied the fetal and maternal effects of 
phenylephrine and  ephedrine during spinal anaesthesia for caesarean 
section. 
 The study was randomized and double blind. It compared 
phenylephrine 100microgm  / ml (Group P) ephedrine 3 mg / ml  
(Group E) and phenylephrine 50 microgm / ml combined with ephedrine 
1.5  mg/ml (Group P/E) given by infusion to maintain systolic blood 
pressure. The study result showed that foetal acidosis was less frequent in 
Group P (1 in 48) (p=0.004) and in Group P/E (1 in 47) (p=0.005) than in 
 ephedrine group (10 of 48). The systolic blood pressure was maintained 
in Group P median 98% of baseline, Group E 100% of base line ,Group 
P/E 101% of baseline.  
The mean heart rate was higher in the Group E than with Group P 
(P<0.0001) nausea and vomiting was less frequent in the Group P 
(Nausea 17% vomitting 0%) Group E (Nausea 66% vomitting 30%) 
Group P/E (Nausea 55% vomitting 18%). 
 They concluded that phenylephrine alone by infusion was 
associated with lower  incidence of fetal acidosis and maternal nausea 
and vomitting than giving ephedrine alone.  
The combination group had no advantage but increased nausea and 
vomitting.  
Loughrey JP et al8 studied  phenylephrine and ephedrine in 
combination and ephedrine alone in the management of spinal 
hypotension in caesarean patients. 
 43 term parturients were randomized to receive a bolus of 
ephedrine 10mg or ephedrine 10mg + phenylephrine 40 microgm. They 
concluded that ephedrine and phenyl ephrine given as an IV bolus at the 
doses selected were not superior to ephedrine alone in treating 
hypotension. 
 Dinesh et al9 compared the effects of phenylephrine, ephedrine and 
mephentermine for maintenance of arterial pressure during spinal 
 anaesthesia in caesarean section. 60 patients posted for elective / 
emergency LSCS under SAB who developed spinal hypotension were 
allocated into 3 groups. Each group (n=20), Group P received phenyl 
ephrine 100 microgm IV bolus, Group E received ephedrine 6 mg IV 
bolus, Group M received mephentermine 6 mg IV bolus.  
 In the above study all three vasopressors effectively maintained 
arterial pressure within 20% limit of base line value though systolic BP 
elevation was high in phenylephrine in first 6 mins of bolus. 
Phenylephrine has a peak effect within one minute, ephedrine 2-5 mins, 
mephentermine 5 min. Phenylephrine 100 microgm is as effective as 
ephedrine 5 mg in restoring arterial  pressure >100 mm Hg. Neonatal 
apgar scores were >7 in all three groups.  
Phenylephrine decreases heart rate significantly which may be 
advantage in cardiac patients and patients in whom tachycardia is 
undesirable.  
Niranjan Maitra et al10 did a comparative study of phenylephrine 
and  mephentermine to increase the arterial blood pressure in spinal 
hypotension for caesarean section. 
 Ephedrine has been used as the agent of choice in treating spinal 
hypotension but the position has been challenged because of its potential 
to cause supra ventricular tachycardia, tachyphylaxis and fetal acidosis.  
  The study group of 90 (n=45) each of the group received either 
phenylephrine 100 microgm or mephentermine 6mg on developing 
hypotension,G roup P showed higher systolic blood pressure than Group 
M and the mean diastolic pressure was significantly higher in Group P in 
comparison to Group M. Heart rate decreased significantly in Group P 
whereas it remained high in Group M and was statistically non-significant 
with values at the onset of hypotension till 30 mins. The systolic blood 
pressure shows peak effect of phenylephrine to occur after 6 mins while 
that of mephentermine after 4 minutes. The incidence of nausea and 
vomiting and other effects was comparable between two groups. The 
apgar scores at 1 and 5 min was also statistically not significant between 
the groups. 
 The conclusion was that both phenylephrine and mephentermine 
maintain systolic blood pressure above hypotensive range though 
phenylephrine might be better because number of doses needed is less 
and it increases diastolic blood pressure more than mephentermine and 
hence mean arterial pressure is increased. Thus it can probably enhance 
organ blood flow more than mephentermine. Mephentermine increases 
heart rate and thus may be avoided in population where the effect may be 
detrimental. 
Edno magalhaes et al11 studied the effects of phenylephrine and 
ephedrine in the treatment of spinal hypotension and their effects on the 
foetus. 60 patients undergoing spinal block with bupivacaine and 
 sufentanil for caesarean section were randomly divided into two groups to 
receive prophylactic ephedrine (Group E, n=30 dose =10mg) or 
phenylephrine (Group P, n=30, dose=80mg) immediately after SAB. 50% 
of the initial dose of vasopressor was given when there was fall in blood 
pressure lower than 80% of base line values. 
 Results showed that Group P patients had higher systolic BP. The 
incidence of nausea and vomitting for Group E was 7 and 4 and that for 
Group P was 10 and 6. The incidence of reactive hypertension was 
similar; 5 in Group E and 4 in Group P. Only one patient in Group P 
developed bradycardia. The above differences were not statistically 
significant. In Group P 28 patients developed hypotension and in Group E 
21 patients developed hypotension. This difference was statistically 
significant (P<0.05). The number of episodes of hypotension was 
significantly higher in Group P( 80 episodes ) than in GroupE ( 29 
episodes ) ( P<0.05) . Group E had a higher proportions of new borns 
with Apgar scores in 1 min was lower than 8 than in Group P and thus 
was statistically significant (P < 0.05 )  As for arterial and venous 
umbilical cord blood gases mean pH in Group E is 7.22 and Group P is 
7.27 P 0 < 0.05 and is  statistically significant.  
Mercier FJ et al12 studied the effect of phenylephrine added to 
prophylactic ephedrine infusion during spinal anaesthesia for elective 
cesarean section. 39 parturients with ASA I-II scheduled for caesarean 
delivery received crystalloid preload 15ml / kg, After giving SAB a 
 vasopressor infusion was started immediately after spinal injection of 
either 2mg / min ephedrine plus 10microgm / min phenylephrine or 2 mg 
/ min ephedrine alone.  
When there was fall in systolic BP 6mg ephedrine bolus doses 
given. Hypotension occurred less frequently in ephedrine- phenylephrine 
group than in ephedrine alone. 37% VS 75% (p=0.02) median 
supplemental ephedrine requirement and nausea scores (0-3) were less in 
the ephedrine – phenylephrine group. Umbilical artery pH values were 
higher in ephedrine-phenylephrine group than in ephedrine alone group. 
Apgar scores were similarly good in both groups. They concluded 
phenylephrine added to infusion of ephedrine halved the incidence of 
hypotension and increased umbilical cord pH. 
Deborah H. Moran et al13 compared phenylephrine and ephedrine 
in the prevention of maternal hypotension following SAB. 60 healthy 
patients electively scheduled for caesarean delivery under spinal 
anaethesia of which Group E (n=29 dose = 10mg IV bolus ) and Group P 
(n=31 dose 80 microgm IV bolus) were given to maintain systolic  blood 
pressure >100mm Hg.  
In Group E umbilical artery pH was 7.28 + 0.01;   umbilical artery 
Pco2 was 56.6 + 1.4 mm Hg; umbilical artery base deficit was 2.2 + 
0.04meq; In Group P umbilical artery pH was 7.32 + 0.01; umbilical 
artery Pco2 was 52.1 + 1.3 mm Hg. Umbilical artery base deficit was 0.38 
+ 0.35 meq. There were significant differences between the groups in pH, 
 Pco2, base deficit  although values obtained were within normal limits. 
There was no differences  between the groups in Neonatal apgar scores. 
Early neonatal neuro behaviour scale  score or maternal nausea and 
vomiting. They concluded that phenylephrine is as effective as ephedrine 
in treatment of maternal hypotension when used in small  incremental 
bolus doses. 
R.F.La Porta et al14 studied the effects of phenylephrine and 
ephedrine for maternal hypotension. 40 patients undergoing caesarean 
section divided into 2 groups Group E (n=20; dose 5mg IV bolus) Group 
P (n=20; dose 40microgm IV bolus) whenever there is fall in maternal 
systolic BP to maintain systolic BP>100mm Hg. 
They studied that noradrenaline concentrations in umbilical artery, 
umbilical vein and maternal vein was higher in Group E than Group P 
patients. They were 6858 + 3689  VS 1674 + 944 pg / ml; (P<0.0001) 
1265 + 758 VZ 395 + 470 pg / ml (P<0.001) and  239 + 165 VS 103 + 
93pg / ml (P<0.01) Comparing blood gas values between  Group E and 
Group P, Statistically significant differences were observed. The Group E  
had higher values, there was no difference in Apgar scores and incidence 
of nausea and vomitting. 
Phenylephrine appears safe in treating maternal hypotension and 
was significantly  associated with lower noradrenaline concentrations in 
mother and neonate. 
 Nishikawa K et al15 studied the use of prophylactic i.m 
phenylephrine to prevent spinal induced hypotension in surgical repair of 
hip fracture in the elderly. 
90 patients aged >65 years undergoing surgery for hip fracture 
under hyperbaric tetra caine  spinal anaesthesia were divided as follows. 
45 normotensive pts (15=1.5mg PE) (15=3mg PE) (15=normal saline) 45  
hypertensive patients (15=1.5mg PE) (15=3mg PE) (15=normal saline).  
All the patients received the drug prophylatically. The incidence of 
hypotension ( >25% decrease in MAP  from base line) was significantly 
lower in the patients who received phenylephrine 1.5 or 3 mg than the 
control groups. Both in normotensive and hypertensive group (p < 0.01). 
the normotensive patient who received 3mg and 1.5mg and hypertensive 
patients who received 3mg had significant lower percentage reduction 
MAP (p<0.05) and required smaller doses of rescue IV ephedrine than 
with other groups.               
 Bradycardia ( heart rate <50bpm) as an adverse effect after i.m 
administration of phenylephrine was not observed in any groups. 
Hypertension occurred in normotensive and hypertensive patients who 
received 3 mg im but not with 1.5 mg im. Studies concluded that 
phenylephrine 1.5mg im given prophylactically was safe with no adverse 
effects. 
 M. Tanaka et al16 determined the 95% effective dose of 
phenylephrine by intermittent IV bolus to prevent spinal hypotension and 
/ or nausea at elective caesarean delivery. 
50 patients undergoing elective ceasarean delivery under SAB were 
selected. The dose of phenylephrine was determined using up-down 
sequential allocation. The first patient was assigned  a 40microgm dose 
and the dose to subsequent patients varied by 10microgm increments or 
decrements. An adequate response was defined as absence of hypotension 
(SBP <80% of base line) and nausea. 
  The ED95 of phenylephrine was estimated as 159microgm 
although least is 120microgm and they concluded ED95 of phenylephrine 
is at least 122microgm. 
E.T. Riley17 had studied the advantage of using phenylephrine in 
preventing  maternal spinal hypotension over ephedrine. As ephedrine 
leads to foetal acidosis the aggressive use of phenylephrine and other 
pure alpha vasoconstrictors is apparently the best  practice. 
In case there is bradycardia associated with high spinal or the 
reflex bradycardia  associated with the use of phenylephrine the use of a 
mixture of ephedrine and phenyl ephrine will keep the heart rate up and 
the dose of ephedrine low enough not to be detrimental to the fetus. 
W.D. Ngan kee et al18 did a randomized  double blinded 
comparison of phenyl  ephrine VS ephedrine for maintaining blood 
 pressure during spinal anaesthesia for non- elective caesarean section. Inj 
phenylephrine 100 microgms VS Ephedrine 10mg for treating 
hypotension (SBP < 100 mm Hg) in 204 pts were studied .Umbilical 
artery and venous pH and base excess were similar between groups. In 
the ephedrine group umbilical artery lactate  concentration was higher 
(2.6 VS 2.4mmol / L p=0.002) and umbilical vein lactate concentration 
was also higher (2.5 VS 2.3 m mol/ L p=0.016). There was also more 
incidence of nausea and vomiting. Clinical neonatal out come was 
similar. The umbilical artery and vein Po2 were lower in the 
phenylephrine group although oxygen content was similar. They 
concluded that phenylephrine and ephedrine are both suitable 
vasopressor.           
Yoon HJ et al19 compared the effects of ephedrine, phenylephrine 
and combination infusion on maternal and fetal effects on spinal 
hypotension for caesarean delivery.  Thirty two parturients were 
randomized into 3 groups to receive ephedrine, phenylephrine or  
combination infusion (Group E, Group P and Group EP) starting with 
spinal anaesthesia.  
Parameters such as systolic blood pressure, pulse rate , cardiac 
index, systemic vascular resistance index were measured before and until 
15 mins after spinal anaesthesia. Rescue boluses for hypotension 
comprised of phenylephrine 100 microgm.  Results showed there were 
no statistically significant differences in all parameters among three 
 groups. However 1 min Apgar score in the Group E was significantly 
lower than Group  (P=0.008). 
 Nausea, vomiting, umbilical vein pH and 5 min Apgar score 
showed no difference.  Three methods are all effective to prevent 
hypotension. However 1 min Apgar score of ephedrine group was 
significantly lower than that of phenylephrine alone group.  
Girish sadhu et al20 studied the effect of vasopressor on the uterine 
blood flow. Recent evidence has shown that maintaining blood pressure 
near baseline was associated with best outcome for the baby with fewer 
side effects for the mother. 
Recent evidence has shown that doses of ephedrine large enough to 
maintain hemostasis after induction of SA may be detrimental in foetal 
acidosis, tachycardia and variable foetal heart rate. Ephedrine caused 
significant hypertension and tachycardia when used to treat spinal 
hypotension. Smaller doses of phenylephrine required when compared to 
ephedrine does not cause  increase in foetal acidosis. This may be due to 
decreased sensitivity of uterine blood vessels to  vasopressors in 
pregnancy and preferential shunting of blood from peripheries to the 
uterine vessels. It dose not cause maternal tachycardia but does cause 
bradycardia as a physiological effect. This may not be detrimental to the 
mother / baby if blood pressure is maintained.  
 M.C.Hennebry21 studied the effect of I.V phenylephrine or 
ephedrine on the ED50 of intrathecal bupivacaine  with  fentanyl  for  
caesarean  section. Prophylactic infusion  of phenylephrine to prevent 
hypotension at caesarean  section  has  been shown to decrease the 
roastral spread  of  intrathecal  plain  levobupivacaine  and  intrathecal  
hyperbaric bupivacaine  by  a median of  two dermatomes compared  
with  ephedrine . The ED50 dose of  bupivacaine  with  phenylephrine 
was 7.8 mgs and with ephedrine it was 7.6mg. systolic BP was 
maintained similar  in both groups. 
 
 MATERIALS AND METHODS 
STUDY DESIGN 
 This is a prospective double blinded randomized study.  
 This study was conducted at Chengalpattu Medical College 
Hospital, Chengalpattu – between May 2010 and October 2010 after 
obtaining approval from  the ethical committee  and written informed 
consent from all patients included in this study.  
         An anaesthetic consultant who does not take part  in the study will 
draw inj.phenylephrine  hydrochloride  and inj. ephedrine hydrochloride  
and code the syringes .He will select patients by drawing lots from the 
operation theatre list for that particular day.  
 An anaesthesia resident will conduct the spinal anaesthesia and 
collect data for the study.   Total patients were 100 of ASA  I & II 
undergoing  inguinal hernia and lower limb orthopedic surgeries. 
SELECTION OF CASES  
Inclusion criteria:  
 ASA I & II 
 Age 20 -50 years 
 Both Sexes  
 Exclusion criteria:  
 ASA III – V 
 Bleeding diasthesis 
 Patient on anticoagulants  
PATIENTS GROUPS 
 Patients were divided into two groups. 
Group – P  (Patients who will be treated with inj. Phenylephrine        
hydrochloride  100 micrograms IV bolus).    
Group – E (Patients who will be treated with inj.Ephedrine 
hydrochloride 6 mg IV bolus) 
 Each group will have 50 patients.  
 A drop in the pre operative base line systolic blood pressure by 
30% of its pre operative base value is taken as a point when the patients 
were treated with either inj. phenylephrine hydrochloride or inj.ephedrine 
hydrochloride  in our study.  
 The data  collected were assessed  statistically. 
 PRE ANAESTHETIC EVALUATION  
 Patient included in the study underwent thorough pre-operative  
evaluation which included  a history of:  
1. Underlying medical illness 
2. Previous  Surgery  
3. Anaesthesia and hospitalization. 
4. Drug   intake. 
Physical Examination : 
1. General condition of the patient.    
2. Height and weight  
3. Examination of CVS,RS for  vital signs 
4. Examination of CNS and Spine. 
5. Airway assessment. 
Investigations: 
Hb, PCV, BT, CT, blood sugar ,blood grouping and crossmatching, 
RFT, ECG, Chest X-ray were done as per the patients surgical 
requirement.  
Patients were advised over night starvation. 
 Technique : 
 Patients were premedicated with tablet midzolam 7.5 mg orally 2 
hours prior to surgery with a sip of water.  
 IV line secured over the left forearm using a 18G IV cannula   and 
was  preloaded  with  Ringer’s lactate 10 ml/ kg which was started and 
ended within one hour before the spinal blockade.  
 Anaesthesia   machine and drug trolley  including emergency drugs 
were checked.  The level of operating theatre table was checked to be 
horizontal. 
 Patient was shifted on a transfer trolley into the operation theatre 
and were connected to  NIBP, SPO2 5 lead ECG monitors.  The pre 
operative base line values of systolic, diastolic and mean arterial blood 
pressure , and SPO2 were recorded in supine position . 
 Then the patient was positioned in the right lateral position and a 
midline lumbar  puncture  was performed using 23G  Quincke  spinal 
needle at L2L3 space  after following a local infiltration with 1ml of  2% 
lignocaine under strict  aseptic  precautions. All patients were given 0.5% 
Bupivacaine heavy   3ml.   The patient was repositioned to supine 
position 
 
 INTRAOPERATIVE DATA    
The data systolic pressure, diastolic pressure,  mean arterial 
pressure, heart rate and SPO2 were recorded every minute for 5 minutes 
and the same parameters were planned to be recorded at every 5th minute 
for 60 minutes. Whenever the patient’s   systolic blood pressure  falls 
below 30% from the baseline value Group P was given inj. 
phenylephedrine hydrochloride100 micrograms  IV bolus and Group E  
was given inj. Ephedrine hydrochloride 6mg  IV bolus. 
For those patients who had a drop in systolic blood pressure below 
30% of  baseline value, systolic blood pressure, diastolic blood pressure, 
mean arterial pressure, heart rate, SPO2 were recorded at an interval of 1 
minute, 3 minute, 5 minute, 10minute, 20 minute, 30 minute, 45 minute,  
and 60 minute . 
Side effects   like headache ,  nausea  and vomiting were observed 
and data collected.  
The data  collected  were assessed statistically.  
 OBSERVATIONS AND RESULTS 
STATISTICAL ANALYSIS 
All collected data were entered into computer using MS Excel 
software and analysed using STATA software. Descriptive analysis 
presented in the form of Tables and Graphs. The level of significance was 
0.05 used for determining the significance of different variable. Student 
‘t’ test was used to determine the significance of quantitative variables of 
demographic data like preoperative, intraoperative and postoperative 
systolic blood pressure(SBP),diastolic blood pressure(DBP),  mean 
arterial pressure(MAP) and heart rate(HR).   
DEMOGRAPHIC DATA 
Distribution of patients by Age group 
Age Group-P Group-E 
20-30 21 10 
31-40 10 19 
41-50 19 21 
 -  
Mean and standard deviation of age of Group-P and Group- E patients 
are 35.4, 38 and 10.5, 9.5 respectively which is not statistically significant 
(p >0.08). The two groups are comparable at the start of surgery. 
 Distribution of patients by Height in cm : 
Height in cm Group-P Group-E 
145-150 12 8 
151-155 17 25 




Mean and standard deviation of  Height of Group-P and          
Group-E patients are 154, 154 and 3.6, 3.2 respectively which is not 
statistically significant(p >0.90). The two groups are comparable at the 
start of surgery. 
 Distribution of patients by weight : 
Weight in kg Group-P Group-E 
30-40 14 10 
41-50 25 27 
51-60 8 11 




Mean and standard deviation of Weight  of Group-P and  
Group-E patients are 45.7, 46.9 and 11.4, 7.4 respectively which is not 
statistically significant(p >0.50). The two groups are comparable at the 
start of surgery. 
 Distribution of patients by BMI group : 
BMI Group-P Group-E 
<=15 10 2 
15-19 9 19 
19-24 26 26 
>24 5 3 
 
 
Mean and standard deviation of BMI of Group-P and Group-E 
patients are 19.4, 19.8 and 5, 3 respectively which is not statistically 
significant(p >0.60). The two groups are comparable at the start of 
surgery. 
 Distribution of average SBP  Within 5 mts of SAB and 1st minute  
after giving vasopressor : 
 
Time Group-P Group-E P value 
Baseline 116 117 0.86 
1min 123 121 0.5 
2min 108 107 0.75 
3min 93 94 0.72 
5min 85 89 0.21 
1 min after vasopressor 150 112 0.0001 
 
 
Table and Figure shows that Within 5 minutes of SAB, there is no 
significant difference between Group-P and Group-E on drop of 
average SPB at different minutes.   
But after administering the drug, the ‘P’ group shows very high 
average SBP compared to Group-E which is statistically highly 
significant (p<0.0001). 
 Distribution of average DBPwithin 5 mts of SAB and 1st minute  after  
giving vasopressor  : 
 
Time Group-P Group-E P value 
Baseline 74 74 0.81 
1min 77 77 0.9 
2min 68 69 0.51 
3min 60 59 0.37 
5min 55 56 0.71 
1 min after vasopressor 90 71 0.0001 
  
 
Table and Figure shows that Within 5 minutes of SAB, there is no 
significant difference between Group-P and Group -E on drop of 
average DBP at different minutes.   
But after administering the drug, the ‘P’ group shows very high 
average DBP compared to Group-E which is statistically highly 
significant (p<0.0001). 
 Distribution of average MAP within 5 mts of SAB and 1st minute 
after  giving  vasopressor : 
 
Time Group-P Group-E P value 
Baseline 88 88 0.9 
1min 92 91 0.56 
2min 80 81 0.71 
3min 70 69 0.57 
5min 63 67 0.25 
1min after vasopressor- 109 82 0.0001 
 
 
Table and Figure shows that Within 5 minutes of SAB, there is no 
significant difference between Group-P and Group-E on drop of 
average MAP at different minutes.   
But after administering the drug, the ‘P’ group shows very high 
average SBP compared to Group-E which is statistically highly 
significant (p<0.0001). 
 Distribution of average HR during Winthin 5 mts of SAB and 1st 
minute  after  giving  vasopressor : 
 
Time Group-P Group-E P value 
Baseline 79 80 0.6 
1min 80 82 0.02 
2min 81 83 0.27 
3min 81 83 0.32 
5min 79 82 0.2 
1min after vasopressor 58 84 0.0001 
 
 
Table and Figure shows that within 5 minutes of SAB, there is no 
significant difference between Group-P and Group-E on average HR at 
different minutes.   
But after administering the drug, the ‘P’ group shows  a fall in the 
heart rate compared to Group-E which is statistically highly significant 
(p<0.0001). 
 Distribution of SBP after giving Vasopressor  Intraoperatively 
Time in mins Group-P Group-E P value 
1 150 112 0.0001 
2 145 113 0.0001 
3 138 112 0.0001 
5 128 114 0.0001 
10 119 114 0.02 
20 113 111 0.21 
30 112 111 0.52 
45 108 111 0.14 
60 108 110 0.34 
 
 
Table and figure reveals that there is significant difference of 
average SBP between two groups  upto 5 minutes, after giving  
vasopressor  but subsequently there is no significant difference. Average 
SBP at the first minute in Group-P and Group-E are 150mm Hg and         
112 mm Hg respectively. 
 Distribution of DBP after giving Vasopressor  Intraoperatively : 
Time in mins Group-P Group-E P value 
1 90 71 0.0001 
2 88 71 0.0001 
3 85 71 0.0001 
5 78 70 0.0001 
10 75 71 0.03 
20 73 71 0.16 
30 72 71 0.48 
45 70 72 0.14 
60 68 71 0.30 
 
 
Table and figure reveals that there is significant difference of 
average DBP between two groups upto 5 minutes, after giving 
vasopressor but subsequently there is no significant difference. Average 
DBP at the first minute in Group-P and Group-E are 90mm Hg and 
71mm Hg respectively. 
 Distribution of MAP after giving Vasopressor  Intraoperatively : 
Time in mins Group-P Group-E P value 
1 110 82 0.0001 
2 106 83 0.0001 
3 100 84 0.0001 
5 91 84 0.0001 
10 86 84 0.30 
20 82 81 0.66 
30 82 82 0.80 
45 81 81 0.85 




Table and figure reveals that there is significant difference of 
average MAP between two groups  upto 5 minutes,  after giving 
vasopressor but subsequently there is no significant difference. Average 
MAP at the first minute in Group-P and Group-E are 110mm Hg and  
82 mm Hg respectively. 
 Distribution of HR after giving Vasopressor  Intraoperatively : 
Time in mins Group-P Group-E P value 
1 58 84 0.0001 
2 58 85 0.0001 
3 59 85 0.0001 
5 64 84 0.0001 
10 66 83 0.0001 
20 71 83 0.0001 
30 74 82 0.0001 
45 75 81 0.0001 
60 74 80 0.0041 
 
 
Table and figure reveals that there is significant difference of 
average HR between two groups throughout the intraoperative period.  
The heart rate of Group-E is always higher than the Group-P which is 
statistically significant. 
 POST-OP  PERIOD 
Distribution of SBP in the Post of Period 
Time in mins Group-P Group-E P value 
30 112 114 0.52 
60 114 116 0.12 
90 115 116 0.35 
130 115 115 0.94 
150 120 116 0.094 




Table and  figure reveals that there is no difference of average SBP 
at different time  between two groups post operatively 
 Distribution of DBP in the Post of Period : 
Time in mins Gr-P Gr-E P value 
30 71 74 0.09 
60 72 73 0.52 
90 74 73 0.90 
130 75 74 0.71 
150 74 73 0.82 




Table and  figure reveals that there is no difference of average DBP 
at different time  between two groups postoperatively. 
 
 
 Distribution of MAP in the Post of Period : 
Time in mins Group-P Group-E P value 
30 83 84 0.49 
60 85 85 0.73 
90 85 85 0.94 
130 85 86 0.83 
150 87 86 0.69 




Table and  figure reveals that there is no difference of average 
MAP at different time  between two groups post operatively. 
 Distribution of HR in the Post of Period : 
Time in mins Group-P Group-E P value 
30 80 82 0.15 
60 80 82 0.12 
90 80 81 0.13 
130 80 82 0.09 
150 80 81 0.20 




Table and  figure reveals that there is no difference of average HR 
at different time  between two groups postoperatively.  
 
 Side effects observed in two groups : 
Side effects  GROUP-P GROUP-E 
HEADACHE 12 0 
 
There was no serious side effects reported in Group-E. 
Cost benefit : 
Cost of one ampoule of  inj. Phenylephrine : Rs. 198 
Cost of One ampoule of inj. Ephedrine  : Rs.   16 
 DISCUSSION 
 There are various studies on the use of inj.Phenylephrine 
hydrochloride in treating spinal hypotension in patients undergoing 
caeserean section. Use of inj.Phenylephrine hydrochloride was shown to 
produce  an improvement  in uterine  perfusion  and was considered as an  
advantage over inj. Ephedrine hydrochloride for the treatment of spinal 
hypotension. The cost of inj. Phenylephrine hydrochloride is around 
Rs.198  when compared to the cost  of  inj. Ephedrine hydrochloride  
which is around Rs.16.  
          Hence our study was aimed to compare inj. Phenylephrine 
hydrochloride  and inj. Ephedrine hydrochloride in  non obstetric  
surgeries where the advantage for maintaining uterine perfusion remains 
irrelevant.  
 In our study  inguinal hernia and lower limb orthopedic sugeries 
were performed under spinal anaesthesia. We used vasopressors  
inj.Phenyl ephrine hydrochloride (Group P) or inj.Ephedrine 
hydrochloride (Group E)  to treat spinal hypotension whenever systolic 
blood pressure  dropped to a level  30% below the baseline value.  We 
found that when inj. Phenylephrine hydrochloride was used there was a 
statistically highly significant  (p<0.0001) rise in systolic blood pressure  
within one minute which corresponds to the study done by Dinesh et al9  
and  Niranjan Maitra et al 10 . 
  In our study we also noticed a  rise in systolic blood pressure 
following inj.Phenylephrine hydrochloride which was associated with 
headache which persisted  till the systolic blood pressure settled after 5 
minutes. The systolic blood pressure settled to a  more  constant value 
with disappearance of headache which suggests that the headache could 
have been due to sudden surge of  systolic blood pressure within 1 
minute.  
  When using   inj.Ephedrine hydrochloride in our study  the systolic 
blood pressure started rising after  2 to5 minutes to an  average of  
112mm Hg  when compared to 150 mm Hg in the inj. Phenylephrine  
hydrochloride group which were similar to the studies done by Dinesh  
et al9.  There  was no incidence of headache with the onset of rise in 
systolic blood pressure in inj.Ephedrine hydrochloride group.  
 The rise in diastolic blood pressure in Group P were also 
statistically highly significant (p<0.0001) within one minute, and settled  
after 10 minutes,  which was similar to the studies done by  Brooker  
et al2.  
 In inj.Ephedrine hydrochloride group the rise in diastolic blood 
pressure within 1 minute was 71 mm Hg in an average when compared   
to an average of  90 mm Hg in inj. Phenylephrine hydrochloride group. 
 Similarly, statistically  highly  significant rise in mean arterial 
pressure with inj.Phenylephrine hydrochloride group which was  
 109mm Hg in an average  was noticed when compared to an average of  
82mm Hg in inj. Ephedrine hydrochloride group.   
 In our  study there was highly statistically  significant (p<0.0001)  
drop in the  heart rate in inj. Phenylephrine hydrochloride group during 
the first five minutes. This drop in the heart rate could be due to the 
baroreceptor  stimuli which gets activated due to increased systemic 
vascular resistance and mean arterial pressure. Hence the drop in the heart 
rate which lasted for five minutes did not require any treatment as shown 
by studies of Brooker et al2 . 
 In inj. Ephedrine hydrochloride  group there was statistically no 
significant change in heart rate as compared to inj.Phenylephrine  
hydrochloride group as per the studies of  Cooper David et al7  and there 
was no incidence of supra ventricular tachycardia as per Nirajan Maitra et 
al10 studies.  
 The phenomenon of tachyphylaxis  as per the studies of Paul cly 
burn4was not met with, in our study since we have not repeated the dose 
of inj. Ephedrine hydrochloride. 
There was statistically significant incidence of transient headache 
in inj. Phenylephrine hydrochloride group which was not found in 
inj.Ephedrine hydrochloride group. 
 There was no statistically significant incidence of nausea and 
vomiting in both the groups which deferred from the study of Ednomagal 
 haes et al11 who met with the incidence of nausea and vomiting for 
Group P (10 and 6) and for Group E (7 and 4  ).This difference may be 
due to limited number of cases in our study. 
POST OPERATIVE PERIOD  
 There was no statistical difference of average systolic blood 
pressure, diastolic blood pressure, mean arterial pressure and heart rate at 
different time intervals between two groups post operatively . 
   
 CONCLUSION 
One of the  commonest complications met with sub arachnoid  
block is spinal hypotension. Various studies have been done on patients 
undergoing  caeserean  section using inj. Phenylephrine hydrochloride  
for the treatment of spinal hypotension.   Inj. Ephedrine hydrochloride is 
conventionally being used for treating  spinal hypotension.  This  has  led 
to our  study in comparing inj.Ephedrine hydrochloride with 
inj.Phenylephrine hydrochloride in treating  spinal hypotension in non –
obstetrics  surgeries.   
In our study we found that inj.Phenylephrine hydrochloride 
produced high rise in systolic blood pressure associated with headache. A 
high rise in diastolic blood pressure and mean arterial pressure was also 
noticed. With inj. Phenylephrine hydrochloride there was significant  fall 
in heart rate  which was not seen in patients treated with  inj.  Ephedrine 
hydrochloride.  
Comparing the hemodynamic effects of inj.  Ephedrine  and inj. 
Phenylephrine groups we conclude that the treatment of spinal 
hypotension with inj.  Ephedrine hydrochloride has lesser fluctuations 
in hemodynamic variables and is also cost – effective and may be 
considered as a better choice of vasopressor  for treating spinal 
hypotension in non-obstetric surgeries. 
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Name:   Age/Sex  IP No. Weight kgs 
 
         Height in cms 
 
Diagnosis:     Surgery : 
 
 
Pre OP Assessment :  
 
 





Premedication  : 
 
Preloading   :  
 
Positioning    : 
 
Needle type    : 
 
Level of dural puncture  : 
 
Volume of drug   : 
 
Sensory level achieved  : 
 
1 min 3 min 5 min 10 min 
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SBP       
DBP       
MAP       
HR       
SPO2       
SENSORY 
LEVEL 




DATA OF PATIENTS 1 - 25 (GROUP - P) 
 







1 MIN  3MIN  5MIN  10 MIN
SBP  DBP  MAP  HR  SPO2 
1  SHANKAR  35  M  60  154  T10  T8  T6  T6  130  80  96  84  100% 
2  DINAKARAN  35  M  45  150  T10  T8  T7  T6  110  80  90  82  100% 
3  KRIBANITHI  35  F  51  152  T10  T8  T6  T6  110  80  90  80  100% 
4  KATHAVARAYAN  50  M 50 153 T10 T8 T7  T6 140 90 106 80 100%
5  ABDUL  42  M 45 149 T12 T11 T10  T6 120 80 93 80 100%
6  KRISHNAN  50  M 54 150 T10 T10 T8  T6 130 80 96 80 100%
7  NETHAN  50  M  70  150  T10  T10  T8  T6  110  80  90  80  100% 
8  KANNAN  47  M  42  155  T11  T11  T10  T6  130  80  96  84  100% 
9  DAVID  29  M  88  152  T11  T10  T7  T7  120  70  86  84  100% 
10  SARAVANAN  28  M  45  156  T10  T8  T6  T6  100  70  80  80  100% 
11  RAJI  35  M  50  151  T10  T10  T7  T6  132  92  105  80  100% 
12  SURESH  28  M  48  148  T10  T8  T6  T6  110  70  83  80  100% 
13  UDHAYAKUMAR  25  M  32  150  T10  T8  T7  T6  120  80  93  80  100% 
14  ANBURAJ  26  M  37  152  T10  T10  T7  T6  110  70  83  80  100% 
15  MURUGAN  27  M  25  158  T10  T8  T8  T6  110  70  83  80  100% 
16  ARJUNAN  50  M 50 157 T10 T10 T8  T7 130 80 96 80 100%
17  PANNEERSELVAM  20  M 25 159 T10 T10 T8  T6 120 80 93 80 100%
18  KASIRAJ  35  M 45 149 T10 T10 T7  T6 110 70 83 80 100%
19  PERUMAL  50  M 48 158 T10 T10 T7  T6 120 70 86 80 100%
20  SHANKAR  35  M  43  150  T12  T11  T10  T7  110  70  83  84  100% 
21  KASI  45  M  50  159  T10  T8  T7  T6  110  80  90  80  100% 
22  GUNASEKARAN  20  M  28  156  T10  T8  T6  T6  130  70  90  80  100% 
23  MANIKANDAN  20  M  36  148  T10  T10  T7  T6  120  70  86  80  100% 
24  THULUKANAM  45  M  48  156  T10  T10  T8  T6  120  80  93  80  100% 




INTRA OP - PERIOD 
 
1 MINUTE  2 MINUTE  3 MINUTE 
S.No  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
1. 128  62  84  83  100%  110  60  76  80  100%  98  55  69  74  100% 
2. 122  82  95  70  100%  120  80  93  80  100%  80  60  60  85  100% 
3. 120  80  93  65  100%  120  80  93  80  100%  100  70  80  85  100% 
4. 140  90  106  86  100%  130  70  90  85  100%  90  60  70  80  100% 
5. 127  90  109  80  100%  127  90  109  84  100%  88  54  65  87  100% 
6. 100  70  80  74  100%  102  70  81  76  100%  100  60  73  78  100% 
7. 140  90  106  64  99%  130  60  83  68  99%  80  60  66  65  100% 
8. 140  90  106  80  100%  118  75  86  84  100%  110  76  85  88  100% 
9. 125  80  97  80  100% 118 75 86 84 100% 90 60 70 80 100%
10. 140  90  106  80  100% 110 76 85 88 100% 90 60 70 90 100%
11. 132  93  78  70  100% 110 60 70 72 100% 90 60 70 80 100%
12. 130  68  88  80  100% 140 90 106 81 100% 90 60 70 82 100%
13. 130  68  88  80  100% 121 78 90 85 100% 90 60 70 84 100%
14. 132  93  78  84  100%  121  80  69  75  100%  90  60  70  80  100% 
15. 130  80  96  85  100%  80  53  62  80  100%  0  0  0  0  0 
16. 130  80  96  86  100%  124  70  88  85  100%  110  60  76  82  100 
17. 110  70  83  85  100%  112  80  90  80  100%  90  60  70  89  100% 
18. 124  80  94  80  100%  100  60  73  82  100%  90  60  70  84  100% 
19. 127  90  109  85  100%  88  54  65  80  100%  0  0  0  0  0% 
20. 127  90  109  84  100%  110  70  84  84  100%  88  54  65  80  100% 
21. 110  70  83  81  100%  100  62  74  80  100%  80  60  66  79  100% 
22. 100  60  73  70  100%  100  62  74  84  100%  110  70  83  85  100% 
23. 100  60  73  82  100%  100  62  74  81  100%  90  54  66  80  100% 
24. 122  72  88  85  100% 98 60 72 88 100% 90 52 64 89 100%








S.No.  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
1. 0  0  0  0  0  150  90  110  60  100%  140  90  106  62  100% 
2. 0  0  0  0  0  150  100  116  59  100%  140  100  113  55  100% 
3. 80  60  66  80  100% 150 100 116 60 100% 140 100 113 62 100%
4. 0  0  0  0  0 170 80 110 55 100% 172 82 112 56 100%
5. 0  0  0  0  0 110 70 84 67 100% 106 68 79 68 100%
6. 90  50  63  70  100%  150  90  110  56  100%  140  90  106  55  100% 
7. 0  0  0  0  0  150  90  110  50  100%  150  92  114  52  100% 
8. 90  60  70  80  100%  125  97  108  49  100%  164  97  115  46  100% 
9. 0  0  0  0  0  140  90  106  50  100%  164  97  115  49  100% 
10. 0  0  0  0  0  164  97  115  50  100%  147  90  104  62  100% 
11. 0  0  0  0  0  127  90  75  60  100%  132  93  78  58  100% 
12. 0  0  0  0  0  164  97  115  56  100%  151  90  110  59  100% 
13. 0  0  0  0  0  164  97  115  57  100%  151  90  110  59  100% 
14. 0  0  0  0  0  140  90  113  60  100%  148  70  96  56  100% 
15. 0  0  0  0  0  164  100  121  54  100%  151  95  115  55  100% 
16. 80  53  36  80  100% 160 90 113 55 100% 157 90 112 52 100%
17. 0  0  0  0  0 164 100 121 60 100% 157 95 115 59 100%
18. 0  0  0  0  0 157 90 112 53 100% 157 95 115 59 100%
19. 0  0  0  0  0  120  70  88  79  100%  110  70  84  56  100% 
20. 0  0  0  0  0  120  70  88  59  100%  110  70  84  55  100% 
21. 0  0  0  0  0  150  90  120  60  100%  126  86  98  59  100% 
22. 80  50  60  82  100%  150  90  120  55  100%  126  84  98  56  100% 
23. 0  0  0  0  0  150  90  120  57  100%  157  90  115  60  100% 
24. 0  0  0  0  0  154  100  118  54  100%  144  92  109  55  100% 








S.No.  SBP DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
1. 110  70  83  60  100%  110  70  83  61  100%  110  72  84  65  100% 
2. 144  110  121  65  100%  130  90  103  65  100%  130  92  105  64  100% 
3. 144  110  121  60  100% 130 90 103 65 100% 130 90 103 70 100%
4. 160  90  113  60  100% 130 70 90 66 100% 120 70 86 68 100%
5. 110  70  84  70  100% 100 70 80 75 100% 110 70 84 76 100%
6. 130  80  96  60  100% 130 80 96 61 100% 140 90 100 60 100%
7. 140  70  86  55  100% 134 76 95 55 98% 130 70 90 54 100%
8. 147  90  104  62  100%  125  86  97  70  100%  121  78  90  61  100% 
9. 147  90  104  62  100%  130  90  109  70  100%  121  78  90  61  100% 
10. 140  90  106  60  100%  121  78  90  61  100%  118  75  86  60  100% 
11. 147  90  104  62  100%  129  89  74  62  100%  123  89  75  62  100% 
12. 140  90  100  60  100%  140  80  100  65  100%  121  78  90  70  100% 
13. 140  80  100  60  100%  140  90  106  65  100%  118  75  100  66  100% 
14. 129  89  74  55  100%  125  90  73  56  100%  123  87  69  58  100% 
15. 160  90  113  56  100%  152  94  113  60  100%  130  68  88  65  100% 
16. 136  70  92  48  100%  100  60  73  89  100%  108  70  82  90  100% 
17. 136  70  66  62  100%  124  80  44  64  100%  110  80  90  60  100% 
18. 136  70  92  60  100% 148 52 84 65 100% 130 68 88 75 100%
19. 130  90  103  58  100% 120 70 88 60 100% 124 72 89 71 100%
20. 106  68  79  52  100% 110 70 84 60 100% 120 70 88 61 100%
21. 150  90  120  61  100% 130 70 100 64 100% 100 60 73 65 100%
22. 150  90  100  56  100% 130 72 107 60 100% 130 70 100 62 100%
23. 130  72  107  65  100%  130  70  100  60  100%  100  62  74  61  100% 
24. 138  94  108  65  100%  127  70  89  72  100%  120  71  87  75  100% 




INTRA OP - PERIOD 
 
 
20 MINUTE   30 MINUTE   45 MINUTE  60 MINUTE 
S.No.  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR SPO2  SBP  DBP  MAP  HR SPO2  SBP  DBP  MAP  HR SPO2 
1. 112  70  84  70  100%  110  70  83  74  100%  100  72  81  72  100%  118  65  82  70  100% 
2. 110  80  90  70  100%  110  70  83  71  100%  112  72  85  74  100%  110  70  83  75  100% 
3. 110  80  90  72  100%  110 70 83 72 100% 112 72  85  74 100% 0 0 0 0 0
4. 120  70  86  70  100%  100 70 33 71 100% 110 60  76  72 100% 110 60 76 70 100%
5. 98  60  72  78  100%  120 70 88 78 100% 110 70  84  78 100% 110 60 84 72 100%
6. 110  80  90  75  100%  130 80 96 75 100% 110 80  90  70 100% 0 0 0 0 0
7. 110  60  76  60  100%  116 69 84 62 100% 100 70  80  64 100% 110 80 90 65 100%
8. 118  77  87  80  100%  119  80  92  62  100%  116  78  90  68  100%  0  0  0  0  0 
9. 118  77  87  80  100%  119  80  92  76  100%  116  78  90  68  100%  0  0  0  0  0 
10. 118  77  87  62  100%  119  80  92  60  100%  116  78  90  68  100%  0  0  0  0  0 
11. 125  90  73  61  100%  123  87  69  65  100%  121  86  69  64  100%  0  0  0  0  0 
12. 118  75  80  71  100%  119  80  92  72  100%  100  60  73  74  100%  116  78  90  70  100% 
13. 119  80  92  70  100%  100  60  73  75  100%  116  78  90  79  100%  0  0  0  0  0 
14. 127  90  75  60  100%  120  80  93  70  100%  118  72  87  71  100%  0  0  0  0  0 
15. 110  70  83  70  100%  110  70  83  75  100%  100  60  73  80  100%  0  0  0  0  0 
16. 111  60  77  88  100%  114  62  79  85  100%  109  60  76  86  100%  0  0  0  0  0 
17. 110  82  91  61  100%  114  62  79  72  100%  110  70  83  79  100%  110  70  83  75  100% 
18. 112  80  90  80  100%  110 70 83 84 100% 100 60  70  85 100% 110 70 83 80 100%
19. 124  80  94  75  100%  110 80 90 72 100% 120 70  88  74 100% 0 0 0 0 0
20. 124  72  89  65  100%  106 70 82 70 100% 100 60  73  72 100% 120 70 88 70 100%
21. 104  60  74  60  100%  100 60 73 69 100% 100 62  74  70 100% 0 0 0 0 0
22. 110  60  70  60  100%  104 60 74 64 100% 100 60  73  60 100% 100 60 73 65 100%
23. 100  60  73  68  100%  100  60  73  69  100%  104  60  74  70  100%  0  0  0  0  0 
24. 119  72  87  78  100%  110  60  74  81  100%  110  72  84  84  100%  100  78  85  85  100% 








S.No.  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL 
1.   100  70  81  80  100%  T10  110  80  90  82  100%  T10 
2.   110  60  76  84  100%  T9  120  70  80  82  100%  T10 
3.   100  70  87  84 100% T10 110 80  90 82 100% T10
4.   110  60  76  86 100% T9 126 70  88 83 100% T10
5.   100  70  80  75 100% T10 110 70  84 76 100% T10
6.   120  70  88  73 100% T10 120 70  88 70 100% T10
7.   100  70  81  84 100% T10 100 70  81 83 100% T10
8.   113  66  77  75  100%  T8  110  68  84  77  100%  T18 
9.   110  60  78  86  100%  T8  120  70  88  83  100%  T9 
10.   120  83  67  70  100%  T8  110  68  84  77  100%  T10 
11.   120  83  67  70  100%  T8  129  89  74  72  100%  T10 
12.   115  73  87  74  100%  T8  116  60  78  70  100%  T10 
13.   110  68  84  70  100%  T8  115  73  87  74  100%  T8 
14.   121  86  69  76  100%  T8  120  83  67  76  100%  T10 
15.   112  80  90  84  100%  T10  114  62  79  80  100%  T10 
16.   110  60  76  84  100%  T8  124  76  92  85  100%  T10 
17.   104  60  74  72  100%  T10  100  60  73  72  100%  T10 
18.   110  70  83  84 100% T10 114 62  79 80 100% T10
19.   120  80  93  84 100% T8 114 80  91 78 100% T10
20.   112  72  85  70 100% T10 106 68  79 72 100% T11
21.   120  80  93  84 100% T10 100 62  74 80 100% T10
22.   110  70  83  80 100% T10 120 80  93 81 100% T10
23.   100  62  74  72  100%  T10  112  80  90  74  100%  T10 
24.   110  72  84  84  100%  T8  125  70  88  86  100%  T10 








S.No  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL
1.   110  80  90  84 100% T11 110 80 90 83 100% T12
2.   122  72  88  84  100%  T10  126  70  88  80  100%  T11 
3.   110  80  90  84  100%  T11  110  80  90  83  100%  T11 
4.   120  70  86  82  100%  T10  130  80  96  72  100%  T11 
5.   112  72  85  74  100%  T11  114  80  91  78  100%  T11 
6.   110  80  90  84 100% T11 120 80 93 86 100% T12
7.   120  84  96  84 100% T11 124 84 97 82 100% T12
8.   116  78  90  70  100%  T10  115  73  87  72  100%  T10 
9.   120  70  88  84  100%  T9  100  70  80  85  100%  T10 
10.   121  86  69  70  100%  T10  115  73  87  72  100%  T12 
11.   118  82  68  74  100%  T10  121  86  69  70  100%  T12 
12.   110  68  84  77 100% T11 120 83 67 70 100% T11
13.   116  60  78  70  100%  T10  120  83  67  72  100%  T12 
14.   129  89  74  72  100%  T11  118  82  68  74  100%  T11 
15.   110  80  90  84  100%  T11  120  80  93  80  100%  T11 
16.   110  80  90  80  100%  T10  124  80  94  79  100%  T11 
17.   126  84  98  74 100% T11 110 72 84 74 100% T11
18.   112  80  90  80 100% T12 110 72 84 79 100% T12
19.   112  72  85  74  100%  T10  120  80  93  75  100%  T11 
20.   114  80  91  78  100%  T11  100  70  80  75  100%  T12 
21.   100  60  73  80  100%  T11  126  84  98  85  100%  T11 
22.   110  80  90  79  100%  T11  120  80  93  70  100%  T11 
23.   110  70  84  70 100% T11 114 62 79 74 100% T12
24.   100  60  72  84 100% T10 120 74 89 85 100% T11








S.No SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SIDE EFFECTS
1. 120  80  93  84  100%  T12  120  80  93  84  100%  T12    
2. 130  80  96  79  100%  T11  130  80  96  80  100%  T12    
3. 120  80  93  84  100% T12 120 80 93  84 100% L1
4. 126  70  88  84  100% T11 130 80 96  74 100% T12 Headache
5. 120  80  93  80  100%  T12  120  80  93  80  100%  L1    
6. 100  70  80  74  100%  T12  120  80  93  75  100%  L1    
7. 131  62  85  80  100%  T12  140  90  106  86  100%  L1    
8. 133  85  104  74  100%  T11  125  77  96  78  100%  T12    
9. 110  70  83  80  100% T10 110 70 83  80 100% T11
10. 133  85  104  74  100% T12 127 90 78  72 100% L1 Headache
11. 127  90  78  72  100%  T12  127  90  78  72  100%  L1    
12. 121  86  69  70  100%  T12  120  83  67  74  100%  L1  Headache 
13. 121  86  69  75  100%  T12  120  83  67  74  100%  L1  Headache 
14. 121  86  69  70  100%  T12  120  80  93  76  100%  L1    
15. 124  70  88  80  100% T12 120 80 93  82 100% L1 Headache
16. 136  70  92  78  100%  T12  120  76  90  80  100%  T12  Headache 
17. 110  70  83  76  100%  T12  120  80  93  70  100%  L1  Headache 
18. 110  82  91  78  100%  C1  126  84  98  74  100%  L1    
19. 124  72  89  76  100%  T11  120  80  93  80  100%  T12    
20. 120  80  93  80  100% T12 120 70 88  81 100% L1
21. 110  70  83  84  100% T12 120 80 93  85 100% L1
22. 120  80  93  84  100%  T12  120  80  93  84  100%  L1    
23. 100  60  73  70  100%  T12  110  70  83  80  100%  L1    
24. 110  60  76  84  100%  T12  110  72  84  85  100%  L1    




DATA OF PATIENTS 26 - 50 (GROUP - P) 
 
 







1 MIN  3MIN  5MIN  10 MIN
SBP  DBP  MAP  HR  SPO2 
26.  KASI  40  M 45 153 T8 T8 T7  T6 110 70 83 80 100%
27.  ARULMANI  38  M 47 153 T10 T8 T7  T6 130 80 96 80 100%
28.  LOGANATHAN  30  M  45  155  T11  T11  T10  T8  110  70  83  84  100% 
29.  SUKUMAR  47  M  65  154  T10  T7  T6  T5  0  0  0  0  0% 
30.   ILAVARASAN  23  M  50  156  T10  T8  T6  T6  120  80  93  80  100% 
31.  MUTHU  45  M  51  157  T11  T11  T10  T7  130  80  96  80  100% 
32.  BALARAMAN  45  M 40 158 T10 T8 T8  T7 120 70 86 80 100%
33.  ARULMANI  38  M 45 156 T11 T11 T10  T7 120 60 80 80 100%
34.  UMA  20  F  31  155  T11  T10  T8  T6  120  60  80  82  100% 
35.  EGAMBARAM  29  M  50  145  T11  T11  T10  T6  110  60  76  72  100% 
36.  MANIKANDAN  20  M  28  154  T10  T8  T7  T6  120  70  86  90  100% 
37.  THANGARAJ  40  M  48  158  T10  T8  T6  T6  110  70  86  80  100% 
38.  DEVENDIRAN  32  M 51 156 T11 T10 T7  T7 140 90 106 84 100%
39.  KUPPUSAMY  43  M  45  160  T10  T10  T7  T6  120  70  86  84  100% 
40.  SENTHIL  26  M  32  154  T10  T10  T7  T6  110  80  90  80  100% 
41.  SUBRAMANI  50  M  48  156  T10  T10  T8  T6  130  80  96  80  100% 
42.  DHINAKARAN  40  M  35  158  T10  T8  T6  T6  110  70  86  80  100% 
43.  MUNUSAMY  21  M 32 149 T8 T7 T6  T6 130 82 98 80 100%
44.   IYYAPPAN  27  M 40 155 T10 T8 T7  T6 140 90 106 90 100%
45.  VENKATESAN  21  M  56  158  T10  T10  T8  T7  110  70  83  84  100% 
46.  SARAVANAN  25  M  49  156  T10  T8  T7  T6  130  80  96  80  100% 
47.  KUPPUSAMY  43  M  49  157  T10  T8  T6  T6  100  70  80  80  100% 
48.  NAGAPAN  50  M  60  151  T10  T8  T7  T6  110  70  83  80  100% 
49.  RAJENDIRAN  50  M 52 154 T10 T8 T8  T7 120 70 86 80 100%
50.  PRAKASH  26  M  32  157  T10  T8  T7  T6  110  80  90  80  100% 
 
 
INTRA OP - PERIOD 
 
1 MINUTE  2 MINUTE  3 MINUTE 
S.No  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
26. 116  76  89  84  100%  100  60  73  85  100%  78  56  63  86  100% 
27. 130  72  91  84  100% 110 60 76 86 100% 100 60 73 86 100%
28. 140  70  133  85  100% 80 50 60 60 100% 0 0 0 0 0
29. 130  90  103  70  100% 94 67 54 70 99% 0 0 0 0 0
30. 100  70  80  74  100% 102 70 81 76 100% 100 60 73 76 100%
31. 140  90  106  82  100%  110  76  85  84  100%  105  69  81  84  100% 
32. 110  60  76  80  100%  110  60  76  82  100%  100  70  33  84  100% 
33. 130  68  88  83  100%  80  50  60  84  100%  0  0  0  0  0 
34. 130  90  109  80  100%  90  50  63  84  100%  0  0  0  0  0 
35. 130  68  88  80  100%  110  70  83  75  100%  90  60  70  74  100% 
36. 130  88  102  84  100%  98  55  69  86  100%  0  0  0  0  0 
37. 100  70  80  72  100%  112  72  85  74  100%  104  62  76  80  100% 
38. 110  60  76  78  100%  114  78  90  80  100%  110  60  73  84  100% 
39. 120  80  93  78  100%  130  70  90  80  100%  90  60  70  84  100% 
40. 128  70  89  80  100%  116  69  94  82  100%  80  60  66  79  100% 
41. 130  80  96  74  100%  130  80  96  78  100%  90  50  63  79  100% 
42. 110  70  83  84  100% 110 70 83 70 100% 100 60 73 70 100%
43. 112  80  90  79  100% 100 60 73 80 100% 90 60 80 84 100%
44. 120  80  93  85  100% 110 70 83 86 100% 90 50 63 80 100%
45. 112  72  85  80  100% 98 70 79 88 100% 80 60 66 90 100%
46. 130  82  98  84  100%  100  72  81  83  100%  99  56  68  86  100% 
47. 120  70  86  84  100%  104  64  77  83  100%  98  70  79  80  100% 
48. 128  70  89  80  100%  110  60  78  82  100%  100  72  81  70  100% 
49. 128  78  94  84  100%  102  60  74  85  100%  90  50  63  70  100% 




INTRA OP - PERIOD 
 
5 MINUTE  1 MINUTE  2 MINUTE 
S.No  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
26. 0  0  0  0  0  150  70  96  60  100%  138  72  94  65  100% 
27. 90  50  63  87  100% 159 70 99 56 100% 150 62 91 59 100%
28. 0  0  0  0  0 150 90 110 57 100% 140 90 106 70 100%
29. 0  0  0  0  0 104 81 67 68 99% 121 88 74 75 100%
30. 90  50  63  70  100% 150 90 110 56 100% 140 90 106 55 100%
31. 90  60  70  81  100%  164  97  115  60  100%  147  90  104  64  100% 
32. 80  60  66  82  100%  160  90  113  70  100%  160  90  113  64  100% 
33. 0  0  0  0  0%  150  90  110  56  100%  150  92  111  57  100% 
34. 0  0  0  0  0%  164  97  115  80  100%  160  90  113  51  100% 
35. 0  0  0  0  0%  160  92  114  55  100%  151  90  110  52  100% 
36. 0  0  0  0  0%  160  100  120  78  100%  150  90  110  60  100% 
37. 80  60  66  75  100%  150  100  116  60  100%  160  90  113  59  100% 
38. 80  50  60  80  100%  157  95  115  56  100%  150  100  116  58  100% 
39. 0  0  0  0  0%  160  90  113  54  100%  150  100  116  55  100% 
40. 0  0  0  0  0%  150  92  114  55  100%  150  100  116  52  100% 
41. 0  0  0  0  0%  150  90  110  55  100%  150  100  116  56  100% 
42. 80  50  60  85  100% 126 84 98 48 100% 150 90 120 48 100%
43. 0  0  0  0  0% 157 95 115 57 100% 136 70 92 98 100%
44. 0  0  0  0  0% 157 68 95 56 100% 160 70 100 52 100%
45. 0  0  0  0  0% 150 100 116 59 100% 130 80 96 60 100%
46. 0  0  0  0  0%  159  72  101  59  100%  140  70  93  55  100% 
47. 80  50  60  86  100%  160  98  118  60  100%  154  96  114  65  100% 
48. 89  64  72  66  100%  154  90  111  55  100%  140  90  106  56  100% 
49. 0  0  0  0  0%  154  100  118  55  100%  164  100  121  56  100% 




INTRA OP - PERIOD 
 
3 MINUTE  5 MINUTE  10 MINUTE 
S.No  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
26.   140  80  100  66  100%  128  72  90  78  100%  120  80  93  79  100% 
27.   148  100  116  60 100% 120 72 88 61  100% 110 72 84 62 100%
28.   140  80  100  55 100% 108 77 64 56  100% 101 72 56 55 100%
29.   121  88  74  60 100% 99 75 62 74  99% 96 71 54 40 99%
30.   140  90  66  60 100% 130 90 103 64  100% 130 80 96 65 100%
31.   125  97  108  66  100%  125  86  97  69  100%  118  75  80  70  100% 
32.   140  90  106  55  100%  144  90  108  69  100%  120  70  80  60  100% 
33.   140  80  100  55  100%  132  80  67  60  100%  110  80  90  62  100% 
34.   150  94  112  51  100%  147  90  104  60  100%  152  94  113  62  100% 
35.   140  80  100  50  100%  110  80  90  48  100%  107  68  58  89  100% 
36.   153  94  113  55  100%  140  90  106  56  100%  130  90  103  59  100% 
37.   140  100  113  58  100%  144  110  121  55  100%  130  90  103  62  100% 
38.   140  90  103  59  100%  124  80  94  60  100%  110  70  83  70  100% 
39.   144  110  121  60  100%  130  70  90  94  100%  130  90  103  70  100% 
40.   140  70  86  60  100%  110  70  83  60  100%  130  70  90  65  100% 
41.   140  90  106  60  100%  128  70  58  65  100%  102  70  81  71  100% 
42.   130  72  101  50 100% 130 70 100 55  100% 110 72 74 56 100%
43.   148  52  84  60 100% 120 80 93 65  100% 110 70 83 70 100%
44.   140  70  93  60 100% 130 60 83 65  100% 128 62 84 70 100%
45.   130  90  103  61 100% 140 70 93 72  100% 120 70 86 74 100%
46.   150  80  96  60  100%  138  92  107  64  100%  128  70  89  64  100% 
47.   149  50  83  60  100%  134  63  86  62  100%  110  70  83  75  100% 
48.   132  90  104  58  100%  110  70  83  60  100%  120  72  88  64  100% 
49.   140  100  113  58  100%  138  70  92  60  100%  110  76  87  61  100% 




INTRA OP - PERIOD 
 
20 MINUTE   30 MINUTE   45 MINUTE  60 MINUTE 
S.No.  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR SPO2  SBP  DBP  MAP  HR SPO2  SBP  DBP  MAP  HR SPO2 
26. 100  72  81  80  100%  120  82  94  81  100%  120  80  93  82  100%  0  0  0  0  0 
27. 100  70  80  64  100%  128  70  89  70  100%  128  74  92  74  100%  0  0  0  0  0 
28. 107  68  58  60  100%  132  80  67  64  100%  110  80  90  70  100%  100  7  80  72  100% 
29. 107  80  67  90  100%  106 99 66 92 100% 108 80 68  90 100% 109 83 70 90 100%
30. 130  80  96  70  100%  110 80 90 75 100% 100 60 73  76 100% 100 70 80 76 100%
31. 118  77  87  72  100%  121  78  90  74  100%  116  70  85  75  100%  0  0  0  0  0 
32. 120  70  80  70  100%  100  60  73  71  100%  100  60  73  69  100%  0  0  0  0  0 
33. 108  77  64  70  100%  110  80  90  75  100%  130  80  96  74  100%  107  68  58  79  100% 
34. 121  78  90  70  100%  118 77 87 75 100% 116 78 90  70 100% 119 80 92 72 100%
35. 108  77  64  90  100%  100 60 73 85 100% 100 60 73  88 100% 0 0 0 0 0
36. 110  70  83  60  100%  110  72  84  65  100%  100  72  81  70  100%  100  72  81  72  100% 
37. 130  90  103  61  100%  112  72  85  70  100%  100  60  73  74  100%  100  62  74  74  100% 
38. 110  60  76  73  100%  114  62  79  69  100%  112  80  90  73  100%  0  0  0  0  0 
39. 120  70  80  75  100%  110  70  83  79  100%  110  60  76  79  100%  0  0  0  0  0 
40. 116  69  84  72  100%  100 70 80 71 100% 110 80 90  78 100% 0 0 0 0 0
41. 100  60  73  72  100%  110 80 90 80 100% 100 70 80  84 100% 110 80 90 80 100%
42. 120  70  80  70  100%  110  72  83  60  100%  104  60  74  62  100%  100  70  83  69  100% 
43. 114  62  79  74  100%  100  60  73  75  100%  110  70  83  76  100%  0  0  0  0  0 
44. 120  72  88  72  100%  110  70  83  70  100%  100  60  73  94  100%  0  0  0  0  0 
45. 110  72  84  65  100%  109  74  85  108 100%  108  70  82  75  100%  100  74  82  80  100% 
46. 110  82  91  76  100%  112 84 93 72 100% 100 78 85  71 100% 0 0 0 0 0
47. 112  74  86  70  100%  116  74  87  80  100%  110  70  83  81  100%  0  0  0  0  0 
48. 124  78  92  65  100%  125  72  89  67  100%  110  70  83  68  100%  0  0  0  0  0 
49. 100  70  80  90  100%  102  70  80  90  100%  108  60  76  71  100%  109  60  76  74  100% 








S.No.  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL 
26.   120  72  88  84 100% T8 110 74  86 85 100% T10
27.   127  70  86  84  100%  T8  130  78  95  85  100%  T10 
28.   110  80  90  80  100%  T8  112  70  86  84  100%  T10 
29.   109  83  70  80  100%  T8  110  82  70  70  100%  T8 
30.   110  80  90  80  100%  T10  120  70  88  84  100%  T10 
31.   115  73  87  75 100% T8 116 78  90 70 100% T9
32.   126  70  88  78 100% T9 120 70  80 80 100% T10
33.   110  80  90  80  100%  T10  114  60  98  79  100%  T10 
34.   110  70  83  78  100%  T8  110  60  78  72  100%  T9 
35.   112  70  86  88  100%  T10  110  80  90  80  100%  T10 
36.   100  70  80  80  100%  T10  118  60  79  84  100%  T10 
37.   112  72  85  84 100% T10 110 80  90 82 100% T10
38.   110  60  76  81  100%  T10  120  70  88  82  100%  T10 
39.   122  72  88  79  100%  T8  120  80  93  78  100%  T10 
40.   131  62  85  79  100%  T10  124  84  97  70  100%  T11 
41.   110  80  90  80  100%  T8  100  70  80  80  100%  T9 
42.   110  70  83  84 100% T10 110 80  90 81 100% T10
43.   100  70  80  84 100% T8 100 80  90 82 100% T10
44.   110  72  84  84  100%  T8  122  78  92  85  100%  T8 
45.   110  78  88  84  100%  T8  112  74  86  80  100%  T10 
46.   110  72  81  84  100%  T8  102  72  82  85  100%  T10 
47.   110  72  84  84  100%  T8  102  72  82  85  100%  T10 
48.   110  60  76  84 100% T8 104 72  82 86 100% T10
49.   110  60  76  84 100% T8 114 72  86 85 100% T10








S.No.  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL 
26.   122  84  96  86  100%  T10  120  86  97  85  100%  T11 
27.   119  78  91  84  100%  T10  110  70  83  80  100%  T11 
28.   114  63  86  80  100%  T10  110  80  90  80  100%  T11 
29.   121  88  74  70  100%  T10  110  82  70  94  100%  T10 
30.   110  80  90  84  100%  T11  120  80  93  86  100%  T11 
31.   113  66  77  75  100%  T10  125  77  96  75  100%  T11 
32.   110  60  76  82  100%  T10  100  60  73  80  100%  T11 
33.   114  63  80  80  100%  T11  110  80  90  82  100%  T11 
34.   120  70  88  70  100%  T10  118  75  86  72  100%  T11 
35.   110  70  83  80  100%  T11  100  60  73  79  100%  T11 
36.   110  80  90  84 100% T11 118 65  82 84 100% T12
37.   100  70  81  84 100% T11 100 70  81 83 100% T11
38.   122  72  88  81 100% T11 120 80  93 83 100% T12
39.   126  70  88  80 100% T11 110 60  76 81 100% T12
40.   120  80  93  75  100%  T12  100  70  81  80  100%  T12 
41.   120  70  88  82  100%  T10  114  80  91  84  100%  T11 
42.   110  80  90  80  100%  T11  110  80  90  82  100%  T11 
43.   118  60  79  85  100%  T11  100  60  73  80  100%  T12 
44.   100  70  80  80  100%  T10  110  62  78  84  100%  T10 
45.   128  70  89  84  100%  T11  120  66  80  85  100%  T11 
46.   120  78  92  84  100%  T10  132  70  90  80  100%  T11 
47.   109  60  76  86  100%  T10  120  74  89  85  100%  T11 
48.   130  72  91  80  100%  T11  128  70  89  84  100%  T11 
49.   124  78  93  80  100%  T11  118  60  79  99  100%  T11 








S.No.  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SIDE EFFECTS
26. 110  70  83  86  100%  T12  120  70  86  85  100%  T12    
27. 121  70  87  84  100%  T11  100  70  80  86  100%  T12    
28. 140  70  133  82  100%  T11  140  70  93  84  100%  T12    
29. 113  83  70  89 100% T11 112 83 71  84 100% T11
30. 120  70  88  85  100%  T12  120  80  93  85  100%  L1    
31. 133  85  104  75  100%  T12  120  80  93  70  100%  T12  Headache 
32. 110  60  76  81  100%  T11  100  60  73  84  100%  T12  Headache 
33. 130  60  83  80  100%  T11  121  60  80  79  100%  T11    
34. 110  70  83  70 100% T12 121 78 90  70 100% T12
35. 130  60  83  80 100% T12 130 60 83  84 100% T12 Headache
36. 100  70  81  80  100%  T12  120  80  93  84  100%  T12    
37. 120  80  93  80  100%  T12  120  80  93  81  100%  L1    
38. 110  70  83  80  100%  T12  100  70  83  84  100%  L1    
39. 120  70  88  71  100%  T12  120  70  88  70  100%  L1    
40. 100  70  81  81 100% L1 130 60 83  79 100% L1
41. 112  72  85  80  100%  T12  120  80  93  80  100%  T12    
42. 120  80  93  83  100%  T12  120  80  93  80  100%  L1    
43. 110  70  83  79  100%  T12  100  70  80  80  100%  L1    
44. 120  78  92  82  100%  T11  110  70  83  84  100%  T12    
45. 110  60  76  84 100% T12 120 78 92  85 100% L1
46. 136  70  92  84 100% T11 124 80 95  86 100% T12
47. 130  70  90  84  100%  T11  115  70  85  78  100%  T12  Headache 
48. 120  76  90  80  100%  T12  120  80  93  82  100%  T12    
49. 180  72  81  80  100%  T12  113  74  87  82  100%  L1    




DATA OF PATIENTS 1 - 25 (GROUP - E) 
 
 







1 MIN  3MIN  5MIN  10 MIN 
                              SBP  DBP  MAP  HR  SPO2 
1  SELVI  35  F  40  156  T10  T8  T8  T6  110  80  90  70  100% 
2  SHANKAR  50  M  41  153  T10  T8  T8  T6  110  70  83  80  100% 
3  BABU  29  M 45 159 T10 T8 T8 T6 110 70 83 80 100%
4  RAJENDIRAN  35  M  42  154  T10  T10  T8  T7  140  90  106  80  100% 
5  HARIKRISHNAN  47  M  48  152  T8  T8  T7  T6  130  70  90  82  100% 
6  VASU  50  M  45  151  T10  T8  T7  T6  100  70  83  80  100% 
7  KANDEPAN  27  M  49  152  T8  T8  T7  T6  110  70  83  80  100% 
8  EGAMBARAM  40  M 45 154 T10 T8 T7 T6 110 70 83 80 100%
9  MARI  40  M 52 156 T10 T8 T7 T6 110 80 90 80 100%
10  MURUGAN  50  M  49  155  T10  T8  T7  T6  110  80  90  80  100% 
11  ARJUNAN  40  M  49  149  T10  T8  T7  T6  130  80  96  78  100% 
12  SIVA  27  M  42  150  T8  T8  T7  T6  130  80  96  78  100% 
13  MANOKAR  50  M  52  152  T10  T8  T6  T6  100  70  80  80  100% 
14  KANNAN  50  M 42 158 T10 T8 T7 T6 130 70 90 90 100%
15  NAGAPPAN  47  M  49  154  T10  T8  T8  T6  100  70  80  80  100% 
16  JAGATHESH  20  M  30  154  T10  T8  T7  T6  110  80  90  80  100% 
17  SARANRAJ  20  M  35  159  T10  T10  T8  T7  120  70  86  80  100% 
18  NAGAPPAN  50  M  50  155  T10  T8  T7  T6  130  80  96  84  100% 
19  VIJAYAN  35  M 49 158 T10 T8 T7 T6 100 70 80 80 100%
20  SHANMUGAM  50  M 45 152 T10 T8 T8 T6 130 60 83 84 100%
21  MEGABABASHIA  40  M  48  156  T10  T10  T8  T6  110  70  83  80  100% 
22  SUKUMAR  47  M  52  155  T10  T8  T7  T6  130  80  96  80  100% 
23  ARUMUGAM  35  M  40  154  T8  T8  T7  T7  110  70  83  80  100% 
24  ASAITHAMBI  50  M  57  149  T11  T10  T7  T6  130  80  96  84  100% 
25  ARUMUGAM  45  M 52 148 T10 T8 T7 T6 110 70 83 80 100%
 
 




S.NO  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
1.   110  84  92  80  100%  100  70  80  82  100%  80  42  54  81  100% 
2.   110  74  86  84  100%  98  70  79  85  100%  80  40  53  79  100% 
3.   132  72  92  78  100%  104  72  82  79  100%  90  60  70  80  100% 
4.   120  70  86  84 100% 90 60 70 80 100% 0 0 0 0 0
5.   130  90  103  80  100%  100  72  81  80  100%  90  50  63  84  100% 
6.   110  64  79  80  100%  102  60  74  84  100%  120  79  92  80  100% 
7.   128  70  89  80  100%  100  62  74  80  100%  90  64  72  84  100% 
8.   111  72  85  84  100%  101  68  79  80  100%  82  54  63  82  100% 
9.   100  60  73  72 100% 102 70 80 80 100% 80 50 60 84 100%
10.   110  74  86  84 100% 100 60 73 85 100% 80 54 62 80 100%
11.   110  70  80  82  100%  80  50  60  84  100%  0  0  0  0  0 
12.   130  80  96  80  100%  127  79  93  85  100%  102  44  61  82  100% 
13.   132  70  90  78  100%  110  78  88  78  100%  90  52  64  79  100% 
14.   130  80  96  84  100%  126  78  94  80  100%  100  60  73  84  100% 
15.   110  72  84  80 100% 108 60 76 81 100% 80 56 64 84 100%
16.   120  82  94  86  100%  109  79  89  84  100%  90  62  71  80  100% 
17.   120  60  80  84  100%  90  45  60  80  100%  0  0  0  0  0 
18.   130  70  90  80  100%  117  60  79  84  100%  90  50  63  85  100% 
19.   110  60  76  80  100%  100  70  80  84  100%  70  50  56  80  100% 
20.   130  70  90  80 100% 121 72 88 84 100% 110 60 76 88 100%
21.   124  70  58  80 100% 100 60 73 82 100% 101 72 81 84 100%
22.   130  90  103  80  100%  100  70  80  84  100%  90  56  67  80  100% 
23.   110  70  83  82  100%  100  58  72  84  100%  80  48  58  80  100% 
24.   110  70  80  84  100%  110  70  80  82  100%  106  70  79  80  100% 








S.NO  SBP DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
1. 0  0  0  0 0% 124 74 90 82 100% 110 74 86 80 100%
2. 0  0  0  0  0%  121  74  89  88  100%  120  60  80  86  100% 
3. 0  0  0  0  0%  121  74  89  84  100%  124  70  88  80  100% 
4. 0  0  0  0  0%  118  72  87  85  100%  122  72  88  85  100% 
5. 0  0  0  0  0%  110  60  76  85  100%  112  72  85  92  100% 
6. 80  49  59  82 100% 128 70 89 89 100% 120 61 80 98 100%
7. 0  0  0  0 0% 110 74 86 80 100% 100 70 80 78 100%
8. 0  0  0  0  0%  120  72  88  80  100%  110  74  86  89  100% 
9. 0  0  0  0  0%  110  70  84  85  100%  106  72  83  86  100% 
10. 0  0  0  0  0%  120  82  94  80  100%  104  72  82  89  100% 
11. 0  0  0  0  0%  108  74  85  85  100%  111  72  85  78  100% 
12. 87  38  51  85 100% 103 43 60 90 100% 109 73 85 84 100%
13. 0  0  0  0  0%  110  72  84  80  100%  108  92  97  85  100% 
14. 90  50  63  80  100%  110  76  87  89  100%  108  78  88  90  100% 
15. 0  0  0  0  0%  100  72  81  80  100%  100  68  78  89  100% 
16. 0  0  0  0  0%  110  74  86  84  100%  120  84  96  89  100% 
17. 0  0  0  0 0% 120 82 94 85 100% 121 60 80 80 100%
18. 0  0  0  0 0% 120 70 86 80 100% 128 78 94 80 100%
19. 0  0  0  0  0%  110  80  90  85  100%  120  70  86  86  100% 
20. 90  60  70  80  100%  132  78  96  90  100%  128  74  92  92  100% 
21. 90  60  70  85  100%  110  70  83  89  100%  120  80  93  88  100% 
22. 0  0  0  0  0%  130  90  103  80  100%  140  70  93  90  100% 
23. 0  0  0  0 0% 121 60 80 88 100% 110 70 83 89 100%
24. 84  60  68  87 100% 100 70 80 86 100% 104 70 81 87 100%
25. 0  0  0  0  0%  110  72  84  89  100%  110  70  83  86  100% 
 
 




S.NO  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
1. 118  74  88  85 100% 106 70 82 80  100% 117 64 81 80 100%
2. 120  73  87  80  100%  119  68  87  80  100%  121  70  87  85  100% 
3. 128  74  92  85  100%  120  60  80  83  100%  118  72  87  80  100% 
4. 110  74  86  89  100%  102  75  84  79  100%  120  70  83  78  100% 
5. 116  62  80  94  100%  110  74  92  88  100%  118  60  79  87  100% 
6. 116  80  92  88 100% 118 72 87 87  100% 110 80 90 80 100%
7. 128  74  82  81 100% 120 60 80 80  100% 120 90 100 88 100%
8. 112  70  84  87  100%  118  69  85  80  100%  121  74  89  80  100% 
9. 116  78  90  80  100%  109  60  76  88  100%  112  72  85  89  100% 
10. 106  74  84  90  100%  108  70  82  88  100%  112  74  86  87  100% 
11. 109  70  83  78  100%  125  76  90  85  100%  127  79  93  90  100% 
12. 117  79  91  86 100% 129 79 93 87  100% 122 78 94 88 100%
13. 16  78  90  80  100%  113  68  83  80  100%  120  72  88  84  100% 
14. 109  74  85  91  100%  112  74  86  94  100%  120  82  94  80  100% 
15. 106  52  70  90  100%  100  60  73  87  100%  124  80  94  88  100% 
16. 121  80  93  88  100%  128  72  90  87  100%  120  60  80  88  100% 
17. 128  70  89  81 100% 110 72 84 78  100% 106 70 82 78 100%
18. 110  60  76  88 100% 117 72 87 89  100% 110 60 76 92 100%
19. 118  72  87  80  100%  117  72  87  80  100%  117  60  79  85  100% 
20. 110  60  76  88  100%  120  74  89  74  100%  124  88  100  75  100% 
21. 110  70  83  88  100%  120  84  96  87  100%  110  80  90  80  100% 
22. 120  74  89  78  100%  128  70  89  85  100%  120  74  89  80  100% 
23. 108  74  85  85 100% 100 60 73 86  100% 120 74 89 81 100%
24. 104  68  80  82 100% 100 68 79 88  100% 100 70 80 92 100%




INTRA OP PERIOD 
 
 
20 MINUTE   30 MINUTE   45 MINUTE  60 MINUTE 
S.NO.  SBP  DBP  MAP  HR  SPO2 SBP  DBP  MAP HR  SPO2 SBP  DBP  MAP HR  SPO2 SBP  DBP  MAP HR  SPO2
1. 118  70  86  80  100% 107 68 81 82 100% 118 60  76 80 100% 0 0 0 0 0
2. 110  82  91  84  100% 128  88  94  83  100% 123  60  80  80  100% 0  0  0  0  0 
3. 119  70  89  84  100% 120  70  80  84  100% 121  60  80  85  100% 0  0  0  0  0 
4. 108  72  84  74  100% 109  60  76  78  100% 100  70  80  75  100% 0  0  0  0  0 
5. 120  74  89  87  100% 120  70  86  79  100% 110  70  83  78  100% 0  0  0  0  0 
6. 110  60  76  88  100% 112 72 85 80 100% 110 81  90 81 100% 0 0 0 0 0
7. 111  81  91  80  100% 106 84 91 80 100% 109 87  94 80 100% 0 0 0 0 0
8. 120  70  83  85  100% 119  64  79  82  100% 124  82  96  81  100% 120  83  92  80  100%
9. 104  75  84  90  100% 120  60  80  88  100% 120  70  86  81  100% 0  0  0  0  0 
10. 114  70  84  86  100% 118  72  87  80  100% 120  68  85  85  100% 0  0  0  0  0 
11. 121  75  89  83  100% 116  73  85  84  100% 106  70  82  85  100% 108  74  85  80  100%
12. 110  60  76  79  100% 116 73 85 78 100% 118 74  87 75 100% 110 66 76 76 100%
13. 118  79  92  85  100% 110  62  78  80  100% 110  70  83  80  100% 0  0  0  0  0 
14. 100  70  80  82  100% 100  74  82  78  100% 110  78  88  79  100% 110  80  90  76  100%
15. 100  70  80  89  100% 107  70  80  72  100% 104  84  90  74  100% 100  70  80  78  100%
16. 110  70  83  89  100% 100  60  73  80  100% 110  80  90  81  100% 110  72  84  82  100%
17. 108  74  85  85  100% 100 60 73 85 100% 110 70  83 80 100% 0 0 0 0 0
18. 122  70  87  87  100% 120 70 86 80 100% 100 78  85 85 100% 110 60 76 80 100%
19. 110  70  83  80  100% 118  72  87  84  100% 119  70  86  80  100% 0  0  0  0  0 
20. 114  68  83  80  100% 118  70  86  85  100% 120  68  85  82  100% 0  0  0  0  0 
21. 121  70  87  85  100% 100  60  73  84  100% 110  82  84  82  100% 0  0  0  0  0 
22. 110  70  83  84  100% 108  72  84  89  100% 100  80  86  85  100% 120  74  89  88  100%
23. 120  82  94  78  100% 109 70 83 80 100% 110 74  86 85 100% 0 0 0 0 0
24. 100  70  80  85  100% 100 70 80 85 100% 100 70  80 82 100% 0 0 0 0 0








S.NO.  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL 
1.   110  74  86  84 100% T8 110 78  88 82 100% T10
2.   120  78  92  80  100%  T8  112  64  78  80  100%  T10 
3.   121  68  85  80  100%  T8  132  70  90  84  100%  T10 
4.   114  64  80  80  100%  T8  120  74  89  80  100%  T10 
5.   124  74  90  80  100%  T8  134  70  91  84  100%  T9 
6.   124  70  84  80 100% T8 120 60  80 84 100% T10
7.   110  74  86  84 100% T8 116 82  93 80 100% T10
8.   110  72  84  84  100%  T8  116  70  85  85  100%  T10 
9.   120  71  87  84  100%  T8  130  70  90  80  100%  T8 
10.   124  70  88  80  100%  T8  114  64  80  84  100%  T10 
11.   110  70  83  76  100%  T8  121  74  90  79  100%  T10 
12.   120  74  89  80 100% T8 125 76  90 82 100% T8
13.   104  82  89  84  100%  T10  102  70  80  80  100%  T10 
14.   112  78  89  84  100%  T8  113  70  84  80  100%  T10 
15.   121  78  92  80  100%  T8  110  70  83  80  100%  T10 
16.   120  84  96  84  100%  T10  121  78  92  80  100%  T10 
17.   130  60  83  84 100% T7 112 74  86 80 100% T8
18.   110  70  83  80 100% T8 121 70  87 84 100% T9
19.   110  70  83  84  100%  T8  110  80  90  80  100%  T10 
20.   122  76  91  80  100%  T8  110  60  76  84  100%  T10 
21.   114  70  84  80  100%  T10  118  74  88  80  100%  T11 
22.   110  80  90  84  100%  T8  124  78  93  85  100%  T9 
23.   110  80  90  84 100% T8 120 70  86 80 100% T10
24.   110  70  80  82 100% T8 100 68  79 84 100% T8








S.NO SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL
1. 120  70  86  80 100% T10 119 72  87 81 100% T11
2. 114  70  84  84  100%  T10  118  72  87  80  100%  T11 
3. 128  70  89  80  100%  T11  132  70  90  81  100%  T11 
4. 124  75  91  80  100%  T10  122  70  87  84  100%  T11 
5. 131  74  93  80  100%  T10  128  60  82  88  100%  T11 
6. 128  72  90  80 100% T10 110 60  76 84 100% T11
7. 118  70  86  82 100% T10 114 72  86 80 100% T11
8. 118  60  79  80  100%  T10  111  60  77  84  100%  T11 
9. 110  60  76  84  100%  T10  112  70  84  80  100%  T10 
10. 118  78  91  80  100%  T10  109  60  76  84  100%  T11 
11. 110  60  73  80  100%  T10  120  80  93  81  100%  T11 
12. 121  72  86  84 100% T10 110 70  83 85 100% T10
13. 110  64  79  85  100%  T11  104  70  81  80  100%  T11 
14. 121  70  87  84  100%  T10  110  72  84  80  100%  T11 
15. 111  74  86  84  100%  T10  109  80  92  85  100%  T11 
16. 110  82  84  84  100%  T11  112  78  89  80  100%  T11 
17. 114  80  91  84 100% T10 121 84  96 85 100% T10
18. 110  78  88  80 100% T10 110 60  76 84 100% T10
19. 112  70  84  80  100%  T10  110  74  86  85  100%  T11 
20. 112  72  85  80  100%  T10  114  74  87  80  100%  T11 
21. 120  80  93  84  100%  T11  110  60  76  80  100%  T12 
22. 126  70  88  80  100%  T10  120  78  92  80  100%  T11 
23. 110  60  76  84 100% T10 112 78  89 80 100% T11
24. 106  70  79  80 100% T10 106 70  79 80 100% T10
25. 100  70  82  83  100%  T11  122  84  96  79  100%  T11 
 
 
POST OP PERIOD 
 
 
150 MINUTE  180 MINUTE 
S.NO  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL  SIDE EFFECTS
1.   114  70  84  80  100%  T11  118  74  88  84  100%  T12  0 
2.   110  62  78  84  100%  T11  112  60  77  80  100%  T12  0
3.   128  62  84  80  100%  T12  125  70  88  85  100%  LI  0
4.   124  70  88  80  100% T11 126 74 91  85 100% T12 0
5.   120  70  86  80  100% T11 110 72 84  84 100% T12 0
6.   112  72  85  80  100%  T12  110  82  91  80  100%  L1  0
7.   121  60  80  84  100%  T11  120  84  96  80  100%  T12  0
8.   119  82  94  80  100%  T11  110  74  86  83  100%  T12  0
9.   108  72  84  80  100%  T11  100  72  81  80  100%  T11  0
10.   110  62  78  85  100% T11 112 70 84  80 100% T12 0
11.   110  68  84  79  100%  T11  110  70  83  70  100%  T12  0
12.   102  58  76  87  100%  T11  114  63  86  88  100%  T12  0
13.   113  64  80  82  100%  T12  112  70  84  80  100%  T12  0
14.   119  70  86  80  100%  T11  120  60  80  84  100%  T12  0
15.   108  70  82  80  100% T11 116 78 79  80 100% T12 0
16.   114  70  84  84  100% T12 118 74 88  80 100% L1 0
17.   116  86  96  80  100%  T11  121  74  89  80  100%  T11  0
18.   122  88  99  84  100%  T11  130  70  90  80  100%  T12  0
19.   100  60  73  80  100%  T11  110  70  83  78  100%  T12  0
20.   120  70  86  80  100%  T11  128  90  102  84  100%  T12  0
21.   120  70  86  84  100% T12 121 70 87  80 100% L1 0
22.   128  74  92  82  100% T12 120 60 80  85 100% T12 0
23.   110  60  76  84  100%  T12  120  72  88  85  100%  T12  0
24.   110  70  80  82  100%  T12  110  70  80  84  100%  T12  0
25.   100  70  81  80  100%  T12  124  84  97  82  100%  T12  0
 
 
DATA OF PATIENTS 26 - 50 (GROUP - E) 
 







1 MIN  3MIN  5MIN  10 MIN
SBP  DBP  MAP  HR  SPO2 
26  BOOPATHY  50  M  52  154  T10  T8  T7  T6  110  70  83  80  100% 
27  ANBAZAGI  25  F  45  148  T10  T10  T8  T6  110  70  83  80  100% 
28  MANIKANDAN  20  M  54  155  T10  T8  T8  T7  110  70  83  80  100% 
29  MOHAN  25  M  52  159  T10  T8  T7  T7  120  80  93  80  100% 
30  DURAIRAJ  48  M 45 155 T8 T8 T7  T6 110 80 90 80 100%
31  KESAVAN  34  M  45  153  T10  T8  T7  T6  110  70  83  80  100% 
32  ADIMULAM  45  M  49  156  T10  T8  T7  T6  110  70  83  80  100% 
33  DEVAN  32  M  40  154  T8  T7  T6  T6  120  70  83  80  100% 
34  ELUMALAI  45  M  52  153  T10  T10  T8  T7  110  60  76  70  100% 
35  MUNUSAMY  40  M 40 154 T10 T8 T7  T6 110 60 76 88 100%
36  VIJAYAKUMARI  40  F 39 159 T10 T10 T8  T7 110 70 83 80 100%
37  PERUMAL  42  M  63  158  T10  T8  T7  T7  160  100  90  80  100% 
38  IYYAPPAN  24  M  45  158  T10  T10  T8  T7  110  70  83  84  100% 
39  VIJAYAKUMAR  20  M  40  149  T10  T7  T6  T6  110  70  83  80  100% 
40  GOVINDASAMY  42  M  78  156  T10  T8  T7  T6  110  70  83  80  100% 
41  NEELAMEGAM  32  M 50 156 T10 T8 T7  T6 110 70 83 80 100%
42  VANITHA  35  F 40 148 T10 T8 T7  T6 110 70 83 80 100%
43  GOVINDAN  40  M  45  156  T10  T8  T7  T6  130  90  103  80  100% 
44  MALAR  35  F  48  147  T12  T10  T6  T6  140  90  106  80  100% 
45  ELUMALAI  50  M  51  157  T10  T9  T8  T6  140  90  106  80  100% 
46  KUPPAN  50  M 43 152 T8 T8 T7  T6 110 80 90 74 100%
47  GOVINDAN  40  M 39 154 T10 T8 T7  T6 110 80 90 80 100%
48  PERIYANDAVAR  35  M  52  156  T12  T11  T10  T6  140  70  93  80  100% 
49  MANIVANAN  40  M  50  154  S  T8  T7  T6  110  70  83  84  100% 




INTRA OP - PERIOD 
 
1 MINUTE  2 MINUTE  3 MINUTE 
S.No  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
26. 110  70  83  84  100%  100  60  73  80  100%  83  58  43  86  100% 
27. 114  84  94  70  100%  107  86  96  85  100%  108  71  86  80  100% 
28. 110  70  83  82  100%  100  82  52  80  100%  76  53  60  60  100% 
29. 131  62  85  78  100% 120 90 100 84 100% 118 60 81 80 100%
30. 106  71  83  85  100% 108 71 86 70 100% 106 71 83 81 100%
31. 120  82  94  80  100%  100  62  74  84  100%  90  58  68  80  100% 
32. 121  72  88  84  100%  101  70  80  85  100%  90  48  62  70  100% 
33. 120  80  93  84  100%  110  60  66  85  100%  90  50  63  80  100% 
34. 110  60  76  84  100% 104 58 76 85 100% 101 60 73 80 100%
35. 120  90  100  78  100% 120 70 86 79 100% 120 70 86 84 100%
36. 130  80  96  84  100%  132  50  78  80  100%  110  70  80  82  100% 
37. 160  100  120  84  100%  150  100  118  80  100%  100  50  66  95  100% 
38. 110  70  83  82  100%  76  53  60  80  100%  0  0  0  0  0 
39. 110  70  83  90  100%  100  60  73  80  100%  83  58  43  100  100% 
40. 140  90  108  91  100% 130 90 103 90 100% 90 72 78 84 100%
41. 110  80  90  100  100% 100 70 80 98 100% 80 60 66 100 100%
42. 120  70  86  80  100%  106  60  75  84  100%  90  50  63  80  100% 
43. 130  100  110  84  100%  121  70  87  80  100%  110  60  78  80  100% 
44. 130  90  103  82  100%  90  63  72  84  100%  0  0  0  0  0 
45. 140  100  113  89  100%  137  98  111  80  100%  110  70  80  82  100% 
46. 130  90  103  80  100% 90 72 78 88 100% 0 0 0 0 0
47. 106  76  86  80  100%  101  60  73  80  100%  70  50  56  84  100% 
48. 153  98  117  89  100%  150  93  114  90  100%  133  85  85  104  100% 
49. 110  60  76  80  100%  101  74  83  87  100%  102  78  86  78  100% 




INTRA OP - PERIOD 
 
5 MINUTE  1 MINUTE  2 MINUTE 
S.No  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
26. 0  0  0  0  0%  108  85  71  90  100%  104  76  61  82  100% 
27. 106  71  83  76  100%  122  72  85  68  100%  130  78  94  69  100% 
28. 0  0  0  0  0%  87  66  55  54  100%  87  66  55  60  100% 
29. 90  60  70  79  100% 104 68 80 92 100% 116 55 83 80 100%
30. 80  50  60  84  100% 122 72 85 80 100% 130 78 94 81 100%
31. 0  0  0  0  0%  130  70  90  82  100%  121  68  75  82  100% 
32. 0  0  0  0  0%  110  74  86  85  100%  104  72  82  80  100% 
33. 0  0  0  0  0%  104  72  82  80  100%  105  62  76  84  100% 
34. 80  50  60  70  100% 112 60 77 75 100% 117 72 87 88 100%
35. 90  60  70  80  100% 116 55 83 86 100% 120 70 86 87 100%
36. 80  50  60  81  100%  110  60  70  85  100%  110  62  78  98  100% 
37. 0  0  0  0  0%  110  70  83  100  100%  110  72  84  90  100% 
38. 0  0  0  0  0%  100  72  52  85  100%  87  66  55  83  100% 
39. 0  0  0  0  0%  108  85  71  112  100%  108  85  71  100  100% 
40. 0  0  0  0  0% 106 70 82 80 100% 125 80 75 80 100%
41. 0  0  0  0  0% 110 80 90 86 100% 110 70 83 80 100%
42. 0  0  0  0  0%  110  70  83  85  100%  104  70  81  86  100% 
43. 90  58  68  89  100%  100  60  73  78  100%  128  70  89  79  100% 
44. 0  0  0  0  0%  99  60  72  82  100%  115  73  87  80  100% 
45. 80  50  60  100  100%  110  60  76  104  100%  110  62  78  98  100% 
46. 0  0  0  0  0% 125 80 75 82 100% 125 77 96 84 100%
47. 0  0  0  0  0%  110  72  84  85  100%  112  60  77  90  100% 
48. 125  77  96  78  100%  102  58  75  81  100%  100  58  76  80  100% 
49. 80  58  65  77  100%  110  82  91  74  100%  104  78  86  85  100% 




INTRA OP - PERIOD 
 
3 MINUTE  5 MINUTE  10 MINUTE 
S.No  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR  SPO2 
26. 110  70  83  84  100%  112  70  84  70  100%  100  62  74  74  100% 
27. 143  77  105  72  100%  126  74  94  70  100%  112  74  86  71  100% 
28. 104  78  86  61  100%  101  72  59  73  100%  110  60  70  74  100% 
29. 118  60  81  82  100% 120 70 86 72 100% 118 60 81 74 100%
30. 112  74  86  83  100% 143 77 105 85 100% 108 71 83 86 100%
31. 120  78  92  80  100%  112  74  86  85  100%  110  70  83  86  100% 
32. 102  70  80  92  100%  121  74  89  89  100%  118  68  84  70  100% 
33. 118  70  86  86  100%  120  70  86  89  100%  110  72  84  90  100% 
34. 119  60  79  89  100% 120 71 87 90 100% 118 72 87 89 100%
35. 118  60  81  70  100% 122 72 85 75 100% 108 71 83 78 100%
36. 108  74  85  90  100%  110  70  80  96  100%  109  70  83  84  100% 
37. 110  70  83  94  100%  110  70  83  90  100%  110  60  76  84  100% 
38. 101  72  59  90  100%  100  70  80  85  100%  104  78  86  86  100% 
39. 104  76  61  112  100%  110  70  83  80  100%  104  76  61  85  100% 
40. 125  80  75  82  100% 112 70 66 99 100% 110 60 78 80 100%
41. 100  60  73  84  100% 100 60 73 85 100% 106 60 75 87 100%
42. 120  72  84  84  100%  118  60  79  78  100%  119  70  86  79  100% 
43. 110  60  76  79  100%  121  74  89  80  100%  125  78  93  84  100% 
44. 103  66  78  80  100%  107  66  84  85  100%  104  65  76  78  100% 
45. 109  70  83  90  100%  110  64  79  85  100%  111  72  85  86  100% 
46. 114  63  86  80  100% 117 81 93 86 100% 122 85 70 87 100%
47. 120  74  92  86  100%  119  74  92  81  100%  121  80  93  88  100% 
48. 114  63  86  92  100%  112  70  86  90  100%  114  63  86  91  100% 
49. 110  80  90  80  100%  112  74  86  80  100%  114  70  84  83  100% 




INTRA OP - PERIOD 
 
 
20 MINUTE   30 MINUTE   45 MINUTE  60 MINUTE 
S.No.  SBP  DBP  MAP  HR  SPO2  SBP  DBP  MAP  HR SPO2  SBP  DBP  MAP  HR SPO2  SBP  DBP  MAP  HR SPO2 
26. 106  73  52  88  100%  100 60 73 78 100% 110 70 83  75 100% 112 70 84 80 100%
27. 103  72  83  70  100%  106  70  83  66  100%  108  79  67  60  100%  106  70  83  70  100% 
28. 101  72  59  73  100%  99  70  58  70  100%  100  70  80  72  100%  0  0  0  0  0 
29. 99  48  65  80  100%  110  70  83  84  100%  100  70  80  80  100%  0  0  0  0  0 
30. 108  79  67  89  100%  103  72  83  75  100%  106  70  83  70  100%  106  70  83  74  100% 
31. 114  74  87  84  100%  118 72 87 85 100% 116 84 94  80 100% 0 0 0 0 0
32. 130  70  90  81  100%  110 70 83 84 100% 110 60 76  85 100% 0 0 0 0 0
33. 110  60  76  91  100%  110  72  84  92  100%  108  70  82  84  100%  110  72  84  88  100% 
34. 120  84  96  88  100%  120  70  86  80  100%  120  72  88  87  100%  0  0  0  0  0 
35. 106  71  83  82  100%  112  74  86  88  100%  108  71  86  86  100%  0  0  0  0  0 
36. 106  70  82  85  100%  111  72  85  80  100%  111  72  85  82  100%  0  0  0  0  0 
37. 99  48  65  80  100%  110 70 83 84 100% 100 70 80  80 100% 110 70 83 80 100%
38. 110  60  70  78  100%  99  70  58  79  100%  110  60  70  76  100%  101  72  59  80  100% 
39. 95  65  51  88  100%  108  85  71  100 100%  106  73  52  96  100%  100  60  73  94  100% 
40. 114  79  66  83  100%  117  81  93  80  100%  116  81  69  80  100%  122  85  70  70  100% 
41. 106  60  75  88  100%  106  70  82  90  100%  104  70  81  83  100%  0  0  0  0  0 
42. 110  70  83  70  100%  116 74 88 78 100% 110 74 86  79 100% 0 0 0 0 0
43. 126  70  88  85  100%  120 72 88 80 100% 120 60 46  81 100% 0 0 0 0 0
44. 111  62  74  77  100%  113  66  77  75  100%  110  68  84  77  100%  110  66  80  78  100% 
45. 108  74  85  80  100%  110  70  83  84  100%  106  70  82  84  100%  0  0  0  0  0 
46. 110  66  80  84  100%  110  68  84  80  100%  116  81  69  85  100%  110  70  83  80  100% 
47. 120  83  98  81  100%  124  80  94  85  100%  110  60  76  80  100%  121  72  88  80  100% 
48. 110  68  84  90  100%  110 66 80 90 100% 0 0 0  0 0 0 0 0 0 0
49. 120  80  93  84  100%  121 82 88 80 100% 110 60 76  85 100% 100 72 81 80 100%




POST OP PERIOD 
 
30 MINUTE  60 MINUTE 
S.No SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL 
26. 113  83  70  80  100%  T8  109  83  70  82  100%  T10 
27. 106  79  66  84  100%  T10  121  88  74  82  100%  T10 
28. 100  72  52  74  100%  T10  99  70  52  78  100%  T11 
29. 100  70  81  84 100% T10 100 70  81 83 100% T10
30. 113  83  70  82 100% T8 121 88  74 82 100% T10
31. 120  72  88  84  100%  T8  121  60  80  80  100%  T10 
32. 120  80  93  84  100%  T8  110  60  76  85  100%  T8 
33. 116  74  88  84  100%  T9  118  70  86  85  100%  T10 
34. 110  62  78  80 100% T8 112 70  84 84 100% T9
35. 100  72  52  80 100% T8 122 84  96 80 100% T10
36. 110  70  80  70  100%  T10  134  94  107  74  100%  T10 
37. 100  70  80  84  100%  T10  100  70  80  83  100%  T10 
38. 110  80  90  82  100%  T10  110  60  70  84  100%  T10 
39. 100  62  74  84  100%  T7  112  70  84  83  100%  T10 
40. 100  70  81  84 100% T10 110 80  90 82 100% T10
41. 110  60  70  80 100% T8 120 70  88 83 100% T9
42. 112  84  93  82  100%  T8  114  70  84  80  100%  T10 
43. 120  70  86  84  100%  T8  110  60  76  80  100%  T10 
44. 121  74  90  80  100%  T8  128  83  101  80  100%  T8 
45. 110  70  80  70  100%  T8  130  90  103  75  100%  T9 
46. 110  70  83  84 100% T8 121 74  90 82 100% T10
47. 121  80  93  84  100%  T8  110  80  90  84  100%  T10 
48. 128  83  101  80  100%  T8  130  90  103  84  100%  T10 
49. 110  82  91  84  100%  T10  100  70  80  80  100%  T10 
50. 110  80  90  84  100%  T8  118  70  86  80  100%  T9 
 
 




S.No SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL 
26.   121  88  74  84 100% T10 110 82  70 80 100% T11
27.   110  82  70  80  100%  T11  109  83  70  82  100%  T12 
28.   110  60  70  70  100%  T11  112  72  64  82  100%  T12 
29.   120  84  96  84  100%  T11  122  84  96  86  100%  T12 
30.   109  83  70  84  100%  T10  113  83  70  82  100%  T11 
31.   110  60  76  82 100% T10 120 74  89 80 100% T11
32.   113  74  87  80 100% T10 111 70  83 80 100% T10
33.   107  74  85  80  100%  T11  114  78  90  82  100%  T12 
34.   114  74  87  80  100%  T10  120  74  89  85  100%  T10 
35.   110  60  70  79  100%  T10  110  80  90  78  100%  T11 
36.   130  98  108  74  100%  T11  120  80  93  79  100%  T11 
37.   120  84  96  84 100% T11 122 84  96 86 100% T11
38.   112  72  64  85  100%  T11  100  70  80  80  100%  T11 
39.   110  60  78  84  100%  T10  110  70  83  82  100%  T12 
40.   110  80  90  84  100%  T11  110  80  90  83  100%  T11 
41.   120  70  88  84  100%  T9  100  70  80  85  100%  T10 
42.   118  60  79  84 100% T11 100 60  73 80 100% T11
43.   118  72  87  84 100% T10 120 60  80 80 100% T11
44.   130  90  103  82  100%  T10  130  92  104  84  100%  T10 
45.   134  94  107  72  100%  T10  140  90  106  70  100%  T11 
46.   128  83  101  80  100%  T10  130  92  104  80  100%  T11 
47.   124  85  98  80  100%  T11  110  60  76  84  100%  T11 
48.   121  74  90  80 100% T10 130 92  104 84 100% T11
49.   100  60  73  84 100% T11 110 72  84 80 100% T11
50.   110  80  90  80  100%  T10  120  70  86  84  100%  T11 
 
 
POST OP PERIOD 
 
150 MINUTE  180 MINUTE 
S.No SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SBP  DBP  MAP  HR  SPO2  SENSORY LEVEL SIDE EFFECTS
26. 126  79  94  85  100%  T11  110  70  83  80  100%  T12  0 
27. 113  83  70  82  100%  T12  113  83  70  84  100%  L1  0 
28. 112  60  72  80  100%  T12  110  80  90  84  100%  L1  0 
29. 122  80  94  82  100% T12 124 84 97  82 100% L1 0
30. 106  79  66  84  100% T11 120 80 93  85 100% T12 0
31. 124  70  88  84  100%  T11  120  81  94  86  100%  T12  0 
32. 124  84  97  80  100%  T11  110  62  78  84  100%  T12  0 
33. 121  76  91  80  100%  T12  106  84  91  84  100%  L1  0 
34. 121  72  88  80  100% T11 110 70 83  80 100% T12 0
35. 124  84  97  74  100% T11 100 70 81  80 100% T12 0
36. 121  88  74  78  100%  T12  130  90  103  70  100%  L1  0 
37. 122  80  94  80  100%  T12  124  84  97  82  100%  T12  0 
38. 102  80  94  85  100%  T12  124  84  97  80  100%  T12  0 
39. 112  72  80  80  100%  L1  112  72  80  80  100%  L1  0 
40. 120  80  93  84  100% T12 120 80 93  84 100% L1 0
41. 110  70  83  80  100% T10 110 70 83  80 100% T11 0
42. 110  70  83  84  100%  T12  120  70  86  80  100%  L1  0 
43. 110  70  83  80  100%  T11  120  72  88  84  100%  T12  0 
44. 132  92  105  82  100%  T12  132  92  105  84  100%  T12  0 
45. 140  90  106  74  100%  T11  130  98  108  70  100%  T12  0 
46. 121  74  90  82  100% T11 128 83 103  80 100% T12 0
47. 108  72  84  80  100%  T12  110  62  78  84  100%  T12  0 
48. 130  90  103  84  100%  T11  130  90  103  84  100%  T12  0 
49. 108  60  76  80  100%  T12  110  72  84  80  100%  L1  0 
50. 118  70  86  80  100%  T11  120  60  90  84  100%  T12  0 
 
